Full Text of SB1585 100th General Assembly
SB1585sam001 100TH GENERAL ASSEMBLY | Sen. Iris Y. Martinez Filed: 3/31/2017
| | 10000SB1585sam001 | | LRB100 11277 SMS 24690 a |
|
| 1 | | AMENDMENT TO SENATE BILL 1585
| 2 | | AMENDMENT NO. ______. Amend Senate Bill 1585 by replacing | 3 | | everything after the enacting clause with the following:
| 4 | | "Section 5. The Regulatory Sunset Act is amended by | 5 | | changing Section 4.28 and by adding Section 4.38 as follows: | 6 | | (5 ILCS 80/4.28) | 7 | | Sec. 4.28. Acts
repealed on January 1, 2018. The following | 8 | | Acts are
repealed on January 1, 2018: | 9 | | The Illinois Petroleum Education and Marketing Act.
| 10 | | The Podiatric Medical Practice Act of 1987. | 11 | | The Acupuncture Practice Act. | 12 | | The Illinois Speech-Language Pathology and Audiology | 13 | | Practice Act. | 14 | | The Interpreter for the Deaf Licensure Act of 2007. | 15 | | The Nurse Practice Act. | 16 | | The Clinical Social Work and Social Work Practice Act. |
| | | 10000SB1585sam001 | - 2 - | LRB100 11277 SMS 24690 a |
|
| 1 | | The Pharmacy Practice Act. | 2 | | The Home Medical Equipment and Services Provider License | 3 | | Act. | 4 | | The Marriage and Family Therapy Licensing Act. | 5 | | The Nursing Home Administrators Licensing and Disciplinary | 6 | | Act. | 7 | | The Physician Assistant Practice Act of 1987. | 8 | | (Source: P.A. 95-187, eff. 8-16-07; 95-235, eff. 8-17-07; | 9 | | 95-450, eff. 8-27-07; 95-465, eff. 8-27-07; 95-617, eff. | 10 | | 9-12-07; 95-639, eff. 10-5-07; 95-687, eff. 10-23-07; 95-689, | 11 | | eff. 10-29-07; 95-703, eff. 12-31-07; 95-876, eff. 8-21-08; | 12 | | 96-328, eff. 8-11-09.) | 13 | | (5 ILCS 80/4.38 new) | 14 | | Sec. 4.38. Act repealed on January 1, 2028. The following | 15 | | Act is repealed on January 1, 2028: | 16 | | The Physician Assistant Practice Act of 1987. | 17 | | Section 7. The Medical Practice Act of 1987 is amended by | 18 | | changing Section 54.5 as follows:
| 19 | | (225 ILCS 60/54.5)
| 20 | | (Section scheduled to be repealed on December 31, 2017)
| 21 | | Sec. 54.5. Physician delegation of authority to physician | 22 | | assistants, advanced practice nurses, and prescribing | 23 | | psychologists.
|
| | | 10000SB1585sam001 | - 3 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (a) Physicians licensed to practice medicine in all its
| 2 | | branches may delegate care and treatment responsibilities to a
| 3 | | physician assistant under guidelines in accordance with the
| 4 | | requirements of the Physician Assistant Practice Act of
1987. A | 5 | | physician licensed to practice medicine in all its
branches may | 6 | | enter into collaborative supervising physician agreements with
| 7 | | no more than 5 full-time equivalent physician assistants , | 8 | | except in a hospital, hospital affiliate, or ambulatory | 9 | | surgical treatment center as set forth by Section 7.7 of the | 10 | | Physician Assistant Practice Act of 1987 as set forth in | 11 | | subsection (a) of Section 7 of the Physician Assistant Practice | 12 | | Act of 1987 .
| 13 | | (b) A physician licensed to practice medicine in all its
| 14 | | branches in active clinical practice may collaborate with an | 15 | | advanced practice
nurse in accordance with the requirements of | 16 | | the Nurse Practice Act. Collaboration
is for the purpose of | 17 | | providing medical consultation,
and no employment relationship | 18 | | is required. A
written collaborative agreement shall
conform to | 19 | | the requirements of Section 65-35 of the Nurse Practice Act. | 20 | | The written collaborative agreement shall
be for
services in | 21 | | the same area of practice or specialty as the collaborating | 22 | | physician in
his or her clinical medical practice.
A written | 23 | | collaborative agreement shall be adequate with respect to | 24 | | collaboration
with advanced practice nurses if all of the | 25 | | following apply:
| 26 | | (1) The agreement is written to promote the exercise of |
| | | 10000SB1585sam001 | - 4 - | LRB100 11277 SMS 24690 a |
|
| 1 | | professional judgment by the advanced practice nurse | 2 | | commensurate with his or her education and experience.
| 3 | | (2) The advance practice nurse provides services based | 4 | | upon a written collaborative agreement with the | 5 | | collaborating physician, except as set forth in subsection | 6 | | (b-5) of this Section. With respect to labor and delivery, | 7 | | the collaborating physician must provide delivery services | 8 | | in order to participate with a certified nurse midwife. | 9 | | (3) Methods of communication are available with the | 10 | | collaborating physician in person or through | 11 | | telecommunications for consultation, collaboration, and | 12 | | referral as needed to address patient care needs.
| 13 | | (b-5) An anesthesiologist or physician licensed to | 14 | | practice medicine in
all its branches may collaborate with a | 15 | | certified registered nurse anesthetist
in accordance with | 16 | | Section 65-35 of the Nurse Practice Act for the provision of | 17 | | anesthesia services. With respect to the provision of | 18 | | anesthesia services, the collaborating anesthesiologist or | 19 | | physician shall have training and experience in the delivery of | 20 | | anesthesia services consistent with Department rules. | 21 | | Collaboration shall be
adequate if:
| 22 | | (1) an anesthesiologist or a physician
participates in | 23 | | the joint formulation and joint approval of orders or
| 24 | | guidelines and periodically reviews such orders and the | 25 | | services provided
patients under such orders; and
| 26 | | (2) for anesthesia services, the anesthesiologist
or |
| | | 10000SB1585sam001 | - 5 - | LRB100 11277 SMS 24690 a |
|
| 1 | | physician participates through discussion of and agreement | 2 | | with the
anesthesia plan and is physically present and | 3 | | available on the premises during
the delivery of anesthesia | 4 | | services for
diagnosis, consultation, and treatment of | 5 | | emergency medical conditions.
Anesthesia services in a | 6 | | hospital shall be conducted in accordance with
Section 10.7 | 7 | | of the Hospital Licensing Act and in an ambulatory surgical
| 8 | | treatment center in accordance with Section 6.5 of the | 9 | | Ambulatory Surgical
Treatment Center Act.
| 10 | | (b-10) The anesthesiologist or operating physician must | 11 | | agree with the
anesthesia plan prior to the delivery of | 12 | | services.
| 13 | | (c) The collaborating supervising physician shall have | 14 | | access to the
medical records of all patients attended by a | 15 | | physician
assistant. The collaborating physician shall have | 16 | | access to
the medical records of all patients attended to by an
| 17 | | advanced practice nurse.
| 18 | | (d) (Blank).
| 19 | | (e) A physician shall not be liable for the acts or
| 20 | | omissions of a prescribing psychologist, physician assistant, | 21 | | or advanced practice
nurse solely on the basis of having signed | 22 | | a
supervision agreement or guidelines or a collaborative
| 23 | | agreement, an order, a standing medical order, a
standing | 24 | | delegation order, or other order or guideline
authorizing a | 25 | | prescribing psychologist, physician assistant, or advanced | 26 | | practice
nurse to perform acts, unless the physician has
reason |
| | | 10000SB1585sam001 | - 6 - | LRB100 11277 SMS 24690 a |
|
| 1 | | to believe the prescribing psychologist, physician assistant, | 2 | | or advanced
practice nurse lacked the competency to perform
the | 3 | | act or acts or commits willful and wanton misconduct.
| 4 | | (f) A collaborating physician may, but is not required to, | 5 | | delegate prescriptive authority to an advanced practice nurse | 6 | | as part of a written collaborative agreement, and the | 7 | | delegation of prescriptive authority shall conform to the | 8 | | requirements of Section 65-40 of the Nurse Practice Act. | 9 | | (g) A collaborating supervising physician may, but is not | 10 | | required to, delegate prescriptive authority to a physician | 11 | | assistant as part of a written collaborative supervision | 12 | | agreement, and the delegation of prescriptive authority shall | 13 | | conform to the requirements of Section 7.5 of the Physician | 14 | | Assistant Practice Act of 1987. | 15 | | (h) (Blank). | 16 | | (i) A collaborating physician shall delegate prescriptive | 17 | | authority to a prescribing psychologist as part of a written | 18 | | collaborative agreement, and the delegation of prescriptive | 19 | | authority shall conform to the requirements of Section 4.3 of | 20 | | the Clinical Psychologist Licensing Act. | 21 | | (Source: P.A. 98-192, eff. 1-1-14; 98-668, eff. 6-25-14; | 22 | | 99-173, eff. 7-29-15 .)
| 23 | | Section 10. The Physician Assistant Practice Act of 1987 is | 24 | | amended by changing Sections 1, 2, 3, 4, 5, 6, 7, 7.5, 7.7, 9, | 25 | | 10, 12, 13, 14.1, 16, 21, 22.2, 22.6, 22.7, 22.11, 22.14, and |
| | | 10000SB1585sam001 | - 7 - | LRB100 11277 SMS 24690 a |
|
| 1 | | 23 and by adding Sections 4.5, 5.3, 5.5, 11.5, and 22.17 as | 2 | | follows:
| 3 | | (225 ILCS 95/1) (from Ch. 111, par. 4601)
| 4 | | (Section scheduled to be repealed on January 1, 2018)
| 5 | | Sec. 1. Legislative purpose. The practice as a physician | 6 | | assistant in the State of
Illinois is hereby declared to affect | 7 | | the public health, safety and welfare
and to be subject to | 8 | | regulation and control in the public interest. The
purpose and | 9 | | legislative intent of this Act is to encourage and promote the
| 10 | | more effective utilization of the skills of physicians by | 11 | | enabling them to
delegate certain health tasks to physician | 12 | | assistants where such delegation
is consistent with the health | 13 | | and welfare of the patient and is conducted
at the direction of | 14 | | and under the responsible supervision of the physician.
| 15 | | It is further declared to be a matter of public health and | 16 | | concern that
the practice as a physician assistant, as defined | 17 | | in this Act, merit and
receive the confidence of the public, | 18 | | that only qualified persons be
authorized to practice as a | 19 | | physician assistant in the State of Illinois.
This Act shall be | 20 | | liberally construed to best carry out these subjects
and | 21 | | purposes.
| 22 | | (Source: P.A. 85-981 .)
| 23 | | (225 ILCS 95/2) (from Ch. 111, par. 4602)
| 24 | | (Section scheduled to be repealed on January 1, 2018)
|
| | | 10000SB1585sam001 | - 8 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Sec. 2. Short title. This Article II shall be known and may | 2 | | be cited as the " Physician
Assistant Practice Act of 1987 " . | 3 | | References in this Article to "this Act" mean this Article.
| 4 | | (Source: P.A. 85-981 .)
| 5 | | (225 ILCS 95/3) (from Ch. 111, par. 4603)
| 6 | | (Section scheduled to be repealed on January 1, 2018)
| 7 | | Sec. 3. Illinois Administrative Procedure Act. The | 8 | | Illinois Administrative Procedure
Act is hereby expressly | 9 | | adopted and incorporated herein as if all of the
provisions of | 10 | | that Act were included in this Act, except that the provision | 11 | | of
subsection (d) of Section 10-65 of the Illinois | 12 | | Administrative Procedure Act
that provides that at hearings the | 13 | | licensee has the right to show compliance
with all lawful | 14 | | requirements for retention, continuation or renewal of the
| 15 | | license is specifically excluded. For the purposes of this Act | 16 | | the notice
required under Section 10-25 of the Illinois | 17 | | Administrative Procedure Act is deemed
sufficient when | 18 | | personally served, mailed to the address of record of the | 19 | | applicant or licensee, or emailed to the email address of | 20 | | record of the applicant or licensee last known address of a | 21 | | party . The Secretary
may adopt
promulgate rules for the | 22 | | administration and enforcement of this Act and may
prescribe | 23 | | forms to be issued in connection with this Act.
| 24 | | (Source: P.A. 95-703, eff. 12-31-07.)
|
| | | 10000SB1585sam001 | - 9 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (225 ILCS 95/4) (from Ch. 111, par. 4604)
| 2 | | (Section scheduled to be repealed on January 1, 2018)
| 3 | | Sec. 4. Definitions. In this Act:
| 4 | | 1. "Department" means the Department of Financial and
| 5 | | Professional Regulation.
| 6 | | 2. "Secretary" means the Secretary
of Financial and | 7 | | Professional Regulation.
| 8 | | 3. "Physician assistant" means any person not holding an | 9 | | active license or permit issued by the Department pursuant to | 10 | | the Medical Practice Act of 1987 who has been
certified as a | 11 | | physician assistant by the National Commission on the
| 12 | | Certification of Physician Assistants or equivalent successor | 13 | | agency and
performs procedures in collaboration with under the | 14 | | supervision of a physician as defined in this
Act. A physician | 15 | | assistant may perform such procedures within the
specialty of | 16 | | the collaborating supervising physician, except that such | 17 | | physician shall
exercise such direction, collaboration, | 18 | | supervision and control over such physician
assistants as will | 19 | | assure that patients shall receive quality medical
care. | 20 | | Physician assistants shall be capable of performing a variety | 21 | | of tasks
within the specialty of medical care under the in | 22 | | collaboration with supervision of a physician.
Collaboration | 23 | | with Supervision of the physician assistant shall not be | 24 | | construed to
necessarily require the personal presence of the | 25 | | collaborating supervising physician at
all times at the place | 26 | | where services are rendered, as long as there is
communication |
| | | 10000SB1585sam001 | - 10 - | LRB100 11277 SMS 24690 a |
|
| 1 | | available for consultation by radio, telephone or
| 2 | | telecommunications within established guidelines as determined | 3 | | by the
physician/physician assistant team. The collaborating | 4 | | supervising physician may delegate
tasks and duties to the | 5 | | physician assistant. Delegated tasks or duties
shall be | 6 | | consistent with physician assistant education, training, and
| 7 | | experience. The delegated tasks or duties shall be specific to | 8 | | the
practice setting and shall be implemented and reviewed | 9 | | under a written collaborative supervision agreement
| 10 | | established by the physician or physician/physician assistant | 11 | | team. A
physician assistant, acting as an agent of the | 12 | | physician, shall be
permitted to transmit the collaborating | 13 | | supervising physician's orders as determined by
the | 14 | | institution's by-laws, policies, procedures, or job | 15 | | description within
which the physician/physician assistant | 16 | | team practices. Physician
assistants shall practice only in | 17 | | accordance with a written collaborative supervision agreement.
| 18 | | Any person who holds an active license or permit issued | 19 | | pursuant to the Medical Practice Act of 1987 shall have that | 20 | | license automatically placed into inactive status upon | 21 | | issuance of a physician assistant license. Any person who holds | 22 | | an active license as a physician assistant who is issued a | 23 | | license or permit pursuant to the Medical Practice Act of 1987 | 24 | | shall have his or her physician assistant license automatically | 25 | | placed into inactive status. | 26 | | 3.5. "Physician assistant practice" means the performance |
| | | 10000SB1585sam001 | - 11 - | LRB100 11277 SMS 24690 a |
|
| 1 | | of procedures within the specialty of the collaborating | 2 | | physician. Physician assistants shall be capable of performing | 3 | | a variety of tasks within the specialty of medical care of the | 4 | | collaborating physician. Collaboration with the physician | 5 | | assistant shall not be construed to necessarily require the | 6 | | personal presence of the collaborating physician at all times | 7 | | at the place where services are rendered, as long as there is | 8 | | communication available for consultation by radio, telephone, | 9 | | telecommunications, or electronic communications. The | 10 | | collaborating physician may delegate tasks and duties to the | 11 | | physician assistant. Delegated tasks or duties shall be | 12 | | consistent with physician assistant education, training, and | 13 | | experience. The delegated tasks or duties shall be specific to | 14 | | the practice setting and shall be implemented and reviewed | 15 | | under a written collaborative agreement established by the | 16 | | physician or physician/physician assistant team. A physician | 17 | | assistant, acting as an agent of the physician, shall be | 18 | | permitted to transmit the collaborating physician's orders as | 19 | | determined by the institution's bylaws, policies, or | 20 | | procedures or the job description within which the | 21 | | physician/physician assistant team practices. Physician | 22 | | assistants shall practice only in accordance with a written | 23 | | collaborative agreement, except as provided in Section 7.5 of | 24 | | this Act. | 25 | | 4. "Board" means the Medical Licensing Board
constituted | 26 | | under the Medical Practice Act of 1987.
|
| | | 10000SB1585sam001 | - 12 - | LRB100 11277 SMS 24690 a |
|
| 1 | | 5. "Disciplinary Board" means the Medical Disciplinary | 2 | | Board constituted
under the Medical Practice Act of 1987.
| 3 | | 6. "Physician" means , for purposes of this Act, a person | 4 | | licensed to
practice medicine in all of its branches under the | 5 | | Medical Practice Act of 1987.
| 6 | | 7. "Collaborating physician" means the physician who, | 7 | | within
his or her specialty and expertise, may delegate a | 8 | | variety of
tasks and procedures to the physician assistant. | 9 | | Such tasks and
procedures shall be delegated in accordance with | 10 | | a written
collaborative agreement. "Supervising Physician" | 11 | | means, for the purposes of this Act, the
primary supervising | 12 | | physician of a physician assistant, who, within his specialty | 13 | | and expertise may delegate a variety of tasks and procedures to
| 14 | | the physician assistant. Such tasks and procedures shall be | 15 | | delegated
in accordance with a written supervision agreement. | 16 | | The supervising physician maintains the
final responsibility | 17 | | for the care of the patient and the performance of the
| 18 | | physician assistant.
| 19 | | 8. "Alternate collaborating supervising physician" means , | 20 | | for the purpose of this Act,
any physician designated by the | 21 | | collaborating supervising physician to collaborate provide
| 22 | | supervision in the event that he or she is unable to | 23 | | collaborate provide that supervision . The Department may | 24 | | further define "alternate collaborating supervising physician" | 25 | | by rule.
| 26 | | The alternate collaborating supervising physicians shall |
| | | 10000SB1585sam001 | - 13 - | LRB100 11277 SMS 24690 a |
|
| 1 | | maintain all the same
responsibilities as the collaborating | 2 | | supervising physician. Nothing in this Act shall
be construed | 3 | | as relieving any physician of the professional or legal
| 4 | | responsibility for the care and treatment of persons attended | 5 | | by him or her or by
physician assistants with under his or her | 6 | | collaboration supervision . Nothing in this Act shall be
| 7 | | construed as to limit the reasonable number of alternate | 8 | | collaborating supervising
physicians, provided they are | 9 | | designated by the supervising physician. | 10 | | 9. "Address of record" means the designated address | 11 | | recorded by the Department in the applicant's or licensee's | 12 | | application file or license file maintained by the Department's | 13 | | licensure maintenance unit. It is the duty of the applicant or | 14 | | licensee to inform the Department of any change of address, and | 15 | | such changes must be made either through the Department's | 16 | | website or by contacting the Department's licensure | 17 | | maintenance unit.
| 18 | | 10. "Hospital affiliate" means a corporation, partnership, | 19 | | joint venture, limited liability company, or similar | 20 | | organization, other than a hospital, that is devoted primarily | 21 | | to the provision, management, or support of health care | 22 | | services and that directly or indirectly controls, is | 23 | | controlled by, or is under common control of the hospital. For | 24 | | the purposes of this definition, "control" means having at | 25 | | least an equal or a majority ownership or membership interest. | 26 | | A hospital affiliate shall be 100% owned or controlled by any |
| | | 10000SB1585sam001 | - 14 - | LRB100 11277 SMS 24690 a |
|
| 1 | | combination of hospitals, their parent corporations, or | 2 | | physicians licensed to practice medicine in all its branches in | 3 | | Illinois. "Hospital affiliate" does not include a health | 4 | | maintenance organization regulated under the Health | 5 | | Maintenance Organization Act. | 6 | | 11. "Email address of record" means the designated email | 7 | | address recorded by the Department in the applicant's | 8 | | application file or the licensee's license file, as maintained | 9 | | by the Department's licensure maintenance unit. | 10 | | (Source: P.A. 99-330, eff. 1-1-16.)
| 11 | | (225 ILCS 95/4.5 new) | 12 | | Sec. 4.5. Address of record; email address of record. All | 13 | | applicants and licensees shall: | 14 | | (1) provide a valid address and email address to the | 15 | | Department, which shall serve as the address of record and | 16 | | email address of record, respectively, at the time of | 17 | | application for licensure or renewal of a license; and | 18 | | (2) inform the Department of any change of address of | 19 | | record or email address of record within 14 days after such | 20 | | change either through the Department's website or by | 21 | | contacting the Department's licensure maintenance unit.
| 22 | | (225 ILCS 95/5) (from Ch. 111, par. 4605)
| 23 | | (Section scheduled to be repealed on January 1, 2018)
| 24 | | Sec. 5. Applicability. This Act does not prohibit:
|
| | | 10000SB1585sam001 | - 15 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (1) any 1. Any person licensed in this State under any | 2 | | other Act from engaging
in the practice for which he is | 3 | | licensed;
| 4 | | (2) the 2. The practice as a physician assistant by a | 5 | | person who is employed
by the United States government or | 6 | | any bureau, division or agency thereof
while in the | 7 | | discharge of the employee's official duties;
| 8 | | (3) the 3. The practice as a physician assistant which | 9 | | is included in their
program of study by students enrolled | 10 | | in schools or in refresher courses
approved by the | 11 | | Department.
| 12 | | 4. The practice, services, or activities of persons | 13 | | practicing the specified occupations set forth in | 14 | | subsection (a) of, and pursuant to a licensing exemption | 15 | | granted in subsection (b) or (d) of, Section 2105-350 of | 16 | | the Department of Professional Regulation Law of the Civil | 17 | | Administrative Code of Illinois, but only for so long as | 18 | | the 2016 Olympic and Paralympic Games Professional | 19 | | Licensure Exemption Law is operable. | 20 | | (Source: P.A. 96-7, eff. 4-3-09.)
| 21 | | (225 ILCS 95/5.3 new) | 22 | | Sec. 5.3. Advertising. | 23 | | (a) As used in this Section, "advertise" means solicitation
| 24 | | by the licensee or through another person or entity by means of | 25 | | hand bills, posters, circulars, motion pictures, radio, |
| | | 10000SB1585sam001 | - 16 - | LRB100 11277 SMS 24690 a |
|
| 1 | | newspapers, or television or any other manner. | 2 | | (b) A person licensed under this Act as a physician | 3 | | assistant may advertise the availability of professional | 4 | | services in the public media or on the premises where the | 5 | | professional services are rendered. The advertising is limited | 6 | | to the following information: | 7 | | (1) publication of the person's name, title, office | 8 | | hours, address, and telephone number; | 9 | | (2) information pertaining to the person's areas of
| 10 | | specialization, including, but not limited to, appropriate | 11 | | board certification or limitation of professional | 12 | | practice; | 13 | | (3) publication of the person's collaborating | 14 | | physician's name, title, and areas of specialization; | 15 | | (4) information on usual and customary fees for routine | 16 | | professional services offered, which shall include | 17 | | notification that fees may be adjusted due to complications | 18 | | or unforeseen circumstances; | 19 | | (5) announcements of the opening of, change of, absence | 20 | | from, or return to business; | 21 | | (6) announcements of additions to or deletions from | 22 | | professional licensed staff; and | 23 | | (7) the issuance of business or appointment cards. | 24 | | (c) It is unlawful for a person licensed under this Act as | 25 | | a physician assistant to use claims of superior quality of care | 26 | | to entice the public. It is unlawful to advertise fee |
| | | 10000SB1585sam001 | - 17 - | LRB100 11277 SMS 24690 a |
|
| 1 | | comparisons of available services with those of other licensed | 2 | | persons. | 3 | | (d) This Section does not authorize the advertising of | 4 | | professional services that the offeror of the services is not | 5 | | licensed or authorized to render. The advertiser shall not use | 6 | | statements that contain false, fraudulent, deceptive, or | 7 | | misleading material or guarantees of success, statements that | 8 | | play upon the vanity or fears of the public, or statements that | 9 | | promote or produce unfair competition. | 10 | | (e) It is unlawful and punishable under the penalty | 11 | | provisions of this Act for a person licensed under this Act to | 12 | | knowingly advertise that the licensee will accept as payment | 13 | | for services rendered by assignment from any third-party payor
| 14 | | the amount the third-party payor covers as payment in full if | 15 | | the effect is to give the impression of eliminating the need of | 16 | | payment by the patient of any required deductible or copayment | 17 | | applicable in the patient's health benefit plan. | 18 | | (f) A licensee shall include in every advertisement for | 19 | | services regulated under this Act his or her title as it | 20 | | appears on the license or the initials authorized under this | 21 | | Act. | 22 | | (225 ILCS 95/5.5 new) | 23 | | Sec. 5.5. Billing. The employer of a physician assistant | 24 | | may charge for services rendered by the physician assistant. | 25 | | All claims for services rendered by the physician assistant |
| | | 10000SB1585sam001 | - 18 - | LRB100 11277 SMS 24690 a |
|
| 1 | | shall be submitted using the physician assistant's national | 2 | | provider identification number as the billing provider | 3 | | whenever appropriate. Payment for services rendered by a | 4 | | physician assistant shall be made to his or her employer if the | 5 | | payor would have made payment had the services been provided by | 6 | | a physician licensed to provide medicine in all of its | 7 | | branches.
| 8 | | (225 ILCS 95/6) (from Ch. 111, par. 4606)
| 9 | | (Section scheduled to be repealed on January 1, 2018)
| 10 | | Sec. 6. Physician assistant title Title; advertising | 11 | | billing .
| 12 | | (a) No physician assistant shall use
the title of doctor or | 13 | | associate with his or her name or any other term that
would | 14 | | indicate to other persons that he or she is qualified to engage | 15 | | in the
general practice of medicine.
| 16 | | (b) No person shall use any words, abbreviations, figures, | 17 | | letters, title, sign, card, or device tending to imply that he | 18 | | or she is a physician assistant, including, but not limited to, | 19 | | using the titles or initials "Physician Assistant" or "PA", or | 20 | | similar titles or initials, with the intention of indicating | 21 | | practice as a physician assistant without meeting the | 22 | | requirements of this Act. A licensee shall include in every | 23 | | advertisement for services regulated
under
this Act his or her | 24 | | title as it appears on the license or the initials
authorized | 25 | | under this Act.
|
| | | 10000SB1585sam001 | - 19 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (c) A physician assistant shall verbally identify himself | 2 | | or herself as a physician assistant, including specialty | 3 | | certification, to each patient. | 4 | | (d) Nothing in this Act shall be construed to relieve a | 5 | | physician assistant of the professional or legal | 6 | | responsibility for the care and treatment of persons attended | 7 | | by him or her. | 8 | | (c) A physician assistant shall not be allowed to bill | 9 | | patients or
in any way to charge for services. Nothing in this | 10 | | Act, however, shall be
so construed as to prevent the employer | 11 | | of a physician assistant from
charging for services rendered by | 12 | | the physician assistant.
Payment for services rendered by a | 13 | | physician assistant shall be made to his or
her employer if the | 14 | | payor would have made payment had the services been
provided by | 15 | | a physician licensed to practice medicine in all its branches.
| 16 | | (d) The supervising physician shall file with the | 17 | | Department notice of
employment, discharge, or supervisory | 18 | | control of a physician assistant at the
time of employment, | 19 | | discharge, or assumption of supervisory control of a
physician | 20 | | assistant.
| 21 | | (Source: P.A. 90-61, eff. 12-30-97; 90-116, eff. 7-14-97; | 22 | | 90-655, eff.
7-30-98; 91-310, eff. 1-1-00 .)
| 23 | | (225 ILCS 95/7) (from Ch. 111, par. 4607)
| 24 | | (Section scheduled to be repealed on January 1, 2018)
| 25 | | Sec. 7. Collaboration Supervision requirements. |
| | | 10000SB1585sam001 | - 20 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (a) A collaborating supervising physician shall determine | 2 | | the number of physician assistants to collaborate with, under | 3 | | his or her supervision provided the physician is able to | 4 | | provide adequate collaboration supervision as outlined in the | 5 | | written collaborative supervision agreement required under | 6 | | Section 7.5 of this Act and consideration is given to the | 7 | | nature of the physician's practice, complexity of the patient | 8 | | population, and the experience of each supervised physician | 9 | | assistant. A collaborating physician may collaborate with a | 10 | | maximum of 5 full-time equivalent physician assistants. The | 11 | | number of physician assistants that the physician collaborates | 12 | | with shall not be reduced by the number of advanced practice | 13 | | nurses with whom the physician holds collaborative agreements. | 14 | | Physicians and physician assistants who work in a hospital, | 15 | | hospital affiliate, or ambulatory surgical treatment center as | 16 | | defined by Section 7.7 of this Act are exempt from the | 17 | | collaborative ratio restriction requirements of this Section. | 18 | | A supervising physician may supervise a maximum of 5 full-time | 19 | | equivalent physician assistants; provided, however, this | 20 | | number of physician assistants shall be reduced by the number | 21 | | of collaborative agreements the supervising physician | 22 | | maintains. A physician assistant shall be able to
hold more | 23 | | than one professional position. A supervising physician shall
| 24 | | file a notice of supervision of each physician assistant | 25 | | according to the
rules of the Department. It is the | 26 | | responsibility of the supervising physician to maintain |
| | | 10000SB1585sam001 | - 21 - | LRB100 11277 SMS 24690 a |
|
| 1 | | documentation each time he or she has designated an alternative | 2 | | supervising physician. This documentation shall include the | 3 | | date alternate supervisory control began, the date alternate | 4 | | supervisory control ended, and any other changes. A supervising | 5 | | physician shall provide a copy of this documentation to the | 6 | | Department, upon request.
| 7 | | Physician assistants shall collaborate be supervised only | 8 | | with by physicians as defined in
this Act
who are engaged in | 9 | | clinical practice, or in clinical practice in
public health or | 10 | | other community health facilities.
| 11 | | Nothing in this Act shall be construed to limit the | 12 | | delegation of tasks or
duties by a physician to a nurse or | 13 | | other appropriately trained personnel.
| 14 | | Nothing in this Act
shall be construed to prohibit the | 15 | | employment of physician assistants by
a hospital, nursing home | 16 | | or other health care facility where such physician
assistants | 17 | | function under a collaborating the supervision of a supervising | 18 | | physician.
| 19 | | A physician assistant may be employed by a practice group | 20 | | or other entity
employing multiple physicians at one or more | 21 | | locations. In that case, one of
the
physicians practicing at a | 22 | | location shall be designated the collaborating supervising
| 23 | | physician. The other physicians with that practice group or | 24 | | other entity who
practice in the same general type of practice | 25 | | or specialty
as the collaborating supervising physician may | 26 | | collaborate with supervise the physician assistant with |
| | | 10000SB1585sam001 | - 22 - | LRB100 11277 SMS 24690 a |
|
| 1 | | respect
to their patients without being deemed alternate | 2 | | supervising physicians for the
purpose of this Act .
| 3 | | (b) A physician assistant licensed in this State, or | 4 | | licensed or authorized to practice in any other U.S. | 5 | | jurisdiction or credentialed by his or her federal employer as | 6 | | a physician assistant, who is responding to a need for medical | 7 | | care created by an emergency or by a state or local disaster | 8 | | may render such care that the physician assistant is able to | 9 | | provide without collaboration supervision as it is defined in | 10 | | this Section or with such supervision as is available.
For | 11 | | purposes of this Section, an "emergency situation" shall not | 12 | | include one that occurs in the place of one's employment. | 13 | | Any physician who collaborates with supervises a physician | 14 | | assistant providing medical care in response to such an | 15 | | emergency or state or local disaster shall not be required to | 16 | | meet the requirements set forth in this Section for a | 17 | | collaborating supervising physician. | 18 | | (Source: P.A. 96-70, eff. 7-23-09; 97-1071, eff. 8-24-12.)
| 19 | | (225 ILCS 95/7.5)
| 20 | | (Section scheduled to be repealed on January 1, 2018)
| 21 | | Sec. 7.5. Written collaborative Prescriptions; written | 22 | | supervision agreements; prescriptive authority. | 23 | | (a) A written collaborative supervision agreement is | 24 | | required for all physician assistants to practice in the State , | 25 | | except as provided in Section 7.7 of this Act . |
| | | 10000SB1585sam001 | - 23 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (1) A written collaborative supervision agreement | 2 | | shall describe the working relationship of the physician | 3 | | assistant with the collaborating supervising physician and | 4 | | shall describe authorize the categories of care, | 5 | | treatment, or procedures to be provided performed by the | 6 | | physician assistant.
The written collaborative supervision | 7 | | agreement shall promote the exercise of professional | 8 | | judgment by the physician assistant commensurate with his | 9 | | or her education and experience. The services to be | 10 | | provided by the physician assistant shall be services that | 11 | | the collaborating supervising physician is authorized to | 12 | | and generally provides to his or her patients in the normal | 13 | | course of his or her clinical medical practice. The written | 14 | | collaborative supervision agreement need not describe the | 15 | | exact steps that a physician assistant must take with | 16 | | respect to each specific condition, disease, or symptom but | 17 | | must specify which authorized procedures require the | 18 | | presence of the collaborating supervising physician as the | 19 | | procedures are being performed. The supervision | 20 | | relationship under a written collaborative supervision | 21 | | agreement shall not be construed to require the personal | 22 | | presence of a physician at the place where services are | 23 | | rendered. Methods of communication shall be available for | 24 | | consultation with the collaborating supervising physician | 25 | | in person or by telecommunications or electronic | 26 | | communications in accordance with established written |
| | | 10000SB1585sam001 | - 24 - | LRB100 11277 SMS 24690 a |
|
| 1 | | guidelines as set forth in the written collaborative | 2 | | supervision agreement. For the purposes of this Act, | 3 | | "generally provides to his or her patients in the normal | 4 | | course of his or her clinical medical practice" means | 5 | | services, not specific tasks or duties, the collaborating | 6 | | supervising physician routinely provides individually or | 7 | | through delegation to other persons so that the physician | 8 | | has the experience and ability to collaborate and provide | 9 | | supervision and consultation. | 10 | | (2) The written collaborative supervision agreement | 11 | | shall be adequate if a physician does each of the | 12 | | following: | 13 | | (A) Participates in the joint formulation and | 14 | | joint approval of orders or guidelines with the | 15 | | physician assistant and he or she periodically reviews | 16 | | such orders and the services provided patients under | 17 | | such orders in accordance with accepted standards of | 18 | | medical practice and physician assistant practice. | 19 | | (B) Provides supervision and consultation at least | 20 | | once a month. | 21 | | (3) A copy of the signed, written collaborative | 22 | | supervision agreement must be available to the Department | 23 | | upon request from both the physician assistant and the | 24 | | collaborating supervising physician. | 25 | | (4) A physician assistant shall inform each | 26 | | collaborating supervising physician of all written |
| | | 10000SB1585sam001 | - 25 - | LRB100 11277 SMS 24690 a |
|
| 1 | | collaborative supervision agreements he or she has signed | 2 | | and provide a copy of these to any collaborating | 3 | | supervising physician upon request. | 4 | | (b) A collaborating supervising physician may, but is not | 5 | | required to, delegate prescriptive authority to a physician | 6 | | assistant as part of a written collaborative supervision | 7 | | agreement. This authority may, but is not required to, include | 8 | | prescription of, selection of, orders for, administration of, | 9 | | storage of, acceptance of samples of, and dispensing over the | 10 | | counter medications, legend drugs, medical gases, and | 11 | | controlled substances categorized as Schedule II III through V | 12 | | controlled substances, as defined in Article II of the Illinois | 13 | | Controlled Substances Act, and other preparations, including, | 14 | | but not limited to, botanical and herbal remedies. The | 15 | | collaborating supervising physician must have a valid, current | 16 | | Illinois controlled substance license and federal registration | 17 | | with the Drug Enforcement Agency to delegate the authority to | 18 | | prescribe controlled substances. | 19 | | (1) To prescribe Schedule II, III, IV, or V controlled | 20 | | substances under this
Section, a physician assistant must | 21 | | obtain a mid-level practitioner
controlled substances | 22 | | license. Medication orders issued by a
physician
assistant | 23 | | shall be reviewed
periodically by the collaborating | 24 | | supervising physician. | 25 | | (2) The collaborating supervising physician shall file
| 26 | | with the Department notice of delegation of prescriptive |
| | | 10000SB1585sam001 | - 26 - | LRB100 11277 SMS 24690 a |
|
| 1 | | authority to a
physician assistant and
termination of | 2 | | delegation, specifying the authority delegated or | 3 | | terminated.
Upon receipt of this notice delegating | 4 | | authority to prescribe Schedule III,
IV, or V controlled | 5 | | substances, the physician assistant shall be eligible to
| 6 | | register for a mid-level practitioner controlled | 7 | | substances license under
Section 303.05 of the Illinois | 8 | | Controlled Substances Act.
Nothing in this Act shall be | 9 | | construed to limit the delegation of tasks or
duties by the | 10 | | collaborating supervising physician to a nurse or other | 11 | | appropriately trained
persons in accordance with Section | 12 | | 54.2 of the Medical Practice Act of 1987.
| 13 | | (3) In addition to the requirements of this subsection | 14 | | (b) of this Section , a collaborating supervising physician | 15 | | may, but is not required to, delegate authority to a | 16 | | physician assistant to prescribe Schedule II controlled | 17 | | substances, if all of the following conditions apply: | 18 | | (A) Specific Schedule II controlled substances by | 19 | | oral dosage or topical or transdermal application may | 20 | | be delegated, provided that the delegated Schedule II | 21 | | controlled substances are routinely prescribed by the | 22 | | collaborating supervising physician. This delegation | 23 | | must identify the specific Schedule II controlled | 24 | | substances by either brand name or generic name. | 25 | | Schedule II controlled substances to be delivered by | 26 | | injection or other route of administration may not be |
| | | 10000SB1585sam001 | - 27 - | LRB100 11277 SMS 24690 a |
|
| 1 | | delegated. | 2 | | (B) Any delegation must be controlled substances | 3 | | that the collaborating supervising physician | 4 | | prescribes. | 5 | | (C) Any prescription must be limited to no more | 6 | | than a 30-day supply, with any continuation authorized | 7 | | only after prior approval of the collaborating | 8 | | supervising physician. | 9 | | (D) The physician assistant must discuss the | 10 | | condition of any patients for whom a controlled | 11 | | substance is prescribed monthly with the collaborating | 12 | | supervising physician. | 13 | | (E) The physician assistant meets the education | 14 | | requirements of Section 303.05 of the Illinois | 15 | | Controlled Substances Act. | 16 | | (c) Nothing in this Act shall be construed to limit the | 17 | | delegation of tasks or duties by a physician to a licensed | 18 | | practical nurse, a registered professional nurse, or other | 19 | | persons. Nothing in this Act shall be construed to limit the | 20 | | method of delegation that may be authorized by any means, | 21 | | including, but not limited to, oral, written, electronic, | 22 | | standing orders, protocols, guidelines, or verbal orders. | 23 | | Nothing in this Act shall be construed to authorize a physician | 24 | | assistant to provide health care services required by law or | 25 | | rule to be performed by a physician. | 26 | | (c-5) Nothing in this Section shall be construed to apply
|
| | | 10000SB1585sam001 | - 28 - | LRB100 11277 SMS 24690 a |
|
| 1 | | to any medication authority, including Schedule II controlled
| 2 | | substances of a licensed physician assistant for care provided
| 3 | | in a hospital, hospital affiliate, or ambulatory surgical
| 4 | | treatment center pursuant to Section 7.7 of this Act.
| 5 | | (d) Any physician assistant who writes a prescription for a | 6 | | controlled substance without having a valid appropriate | 7 | | authority may be fined by the Department not more than $50 per | 8 | | prescription, and the Department may take any other | 9 | | disciplinary action provided for in this Act. | 10 | | (e) Nothing in this Section shall be construed to prohibit | 11 | | generic substitution. | 12 | | (Source: P.A. 96-268, eff. 8-11-09; 96-618, eff. 1-1-10; | 13 | | 96-1000, eff. 7-2-10; 97-358, eff. 8-12-11.)
| 14 | | (225 ILCS 95/7.7) | 15 | | (Section scheduled to be repealed on January 1, 2018) | 16 | | Sec. 7.7. Physician assistants in hospitals, hospital | 17 | | affiliates, or ambulatory surgical treatment centers. | 18 | | (a) A physician assistant may provide services in a | 19 | | hospital or a hospital affiliate as those terms are defined in | 20 | | the Hospital Licensing Act or the University of Illinois | 21 | | Hospital Act or a licensed ambulatory surgical treatment center | 22 | | without a written collaborative supervision agreement pursuant | 23 | | to Section 7.5 of this Act. A physician assistant must possess | 24 | | clinical privileges recommended by the hospital medical staff | 25 | | and granted by the hospital or the consulting medical staff |
| | | 10000SB1585sam001 | - 29 - | LRB100 11277 SMS 24690 a |
|
| 1 | | committee and ambulatory surgical treatment center in order to | 2 | | provide services. The medical staff or consulting medical staff | 3 | | committee shall periodically review the services of physician | 4 | | assistants granted clinical privileges, including any care | 5 | | provided in a hospital affiliate. Authority may also be granted | 6 | | when recommended by the hospital medical staff and granted by | 7 | | the hospital or recommended by the consulting medical staff | 8 | | committee and ambulatory surgical treatment center to | 9 | | individual physician assistants to select, order, and | 10 | | administer medications, including controlled substances, to | 11 | | provide delineated care. In a hospital, hospital affiliate, or | 12 | | ambulatory surgical treatment center, the attending physician | 13 | | shall determine a physician assistant's role in providing care | 14 | | for his or her patients, except as otherwise provided in the | 15 | | medical staff bylaws or consulting committee policies. | 16 | | (a-5) Physician assistants practicing in a hospital | 17 | | affiliate may be, but are not required to be, granted authority | 18 | | to prescribe Schedule II through V controlled substances when | 19 | | such authority is recommended by the appropriate physician | 20 | | committee of the hospital affiliate and granted by the hospital | 21 | | affiliate. This authority may, but is not required to, include | 22 | | prescription of, selection of, orders for, administration of,
| 23 | | storage of, acceptance of samples of, and dispensing | 24 | | over-the-counter medications, legend drugs, medical gases, and | 25 | | controlled substances categorized as Schedule II through V | 26 | | controlled substances, as defined in Article II of the Illinois |
| | | 10000SB1585sam001 | - 30 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Controlled Substances Act, and other preparations, including, | 2 | | but not limited to, botanical and herbal remedies. | 3 | | To prescribe controlled substances under this subsection | 4 | | (a-5), a physician assistant must obtain a mid-level | 5 | | practitioner controlled substance license. Medication orders | 6 | | shall be reviewed periodically by the appropriate hospital | 7 | | affiliate physicians committee or its physician designee. | 8 | | The hospital affiliate shall file with the Department | 9 | | notice of a grant of prescriptive authority consistent with | 10 | | this subsection (a-5) and termination of such a grant of | 11 | | authority in accordance with rules of the Department. Upon | 12 | | receipt of this notice of grant of authority to prescribe any | 13 | | Schedule II through V controlled substances, the licensed | 14 | | physician assistant may register for a mid-level practitioner | 15 | | controlled substance license under Section 303.05 of the | 16 | | Illinois Controlled Substances Act. | 17 | | In addition, a hospital affiliate may, but is not required | 18 | | to, grant authority to a physician assistant to prescribe any | 19 | | Schedule II controlled substances if all of the following | 20 | | conditions apply: | 21 | | (1) specific Schedule II controlled substances by oral | 22 | | dosage or topical or transdermal application may be | 23 | | designated, provided that the designated Schedule II | 24 | | controlled substances are routinely prescribed by | 25 | | physician assistants in their area of certification; this | 26 | | grant of authority must identify the specific Schedule II |
| | | 10000SB1585sam001 | - 31 - | LRB100 11277 SMS 24690 a |
|
| 1 | | controlled substances by either brand name or generic name; | 2 | | authority to prescribe or dispense Schedule II controlled | 3 | | substances to be delivered by injection or other route of | 4 | | administration may not be granted; | 5 | | (2) any grant of authority must be controlled | 6 | | substances limited to the practice of the physician | 7 | | assistant; | 8 | | (3) any prescription must be limited to no more than a | 9 | | 30-day supply; | 10 | | (4) the physician assistant must discuss the condition | 11 | | of any patients for whom a controlled substance is | 12 | | prescribed monthly with the appropriate physician | 13 | | committee of the hospital affiliate or its physician | 14 | | designee; and | 15 | | (5) the physician assistant must meet the education | 16 | | requirements of Section 303.05 of the Illinois Controlled | 17 | | Substances Act. | 18 | | (b) A physician assistant granted authority to order | 19 | | medications including controlled substances may complete | 20 | | discharge prescriptions provided the prescription is in the | 21 | | name of the physician assistant and the attending or | 22 | | discharging physician. | 23 | | (c) Physician assistants practicing in a hospital, | 24 | | hospital affiliate, or an ambulatory surgical treatment center | 25 | | are not required to obtain a mid-level controlled substance | 26 | | license to order controlled substances under Section 303.05 of |
| | | 10000SB1585sam001 | - 32 - | LRB100 11277 SMS 24690 a |
|
| 1 | | the Illinois Controlled Substances Act.
| 2 | | (Source: P.A. 97-1071, eff. 8-24-12.)
| 3 | | (225 ILCS 95/9) (from Ch. 111, par. 4609)
| 4 | | (Section scheduled to be repealed on January 1, 2018)
| 5 | | Sec. 9. Application for licensure. Applications for | 6 | | original licenses
shall be made to the
Department in writing on | 7 | | forms or electronically as prescribed by the Department and | 8 | | shall be
accompanied by the required fee, which shall not be | 9 | | refundable. An
application shall require information that in | 10 | | the judgment
of the
Department will enable the Department to | 11 | | pass on the qualifications of the
applicant for a license. An | 12 | | application shall include evidence of
passage of the | 13 | | examination of the National Commission on the Certification of
| 14 | | Physician Assistants, or its successor agency, and proof that | 15 | | the applicant
holds a valid certificate issued by that | 16 | | Commission.
| 17 | | Applicants have 3 years from the date of application to | 18 | | complete the
application process. If the process has not been | 19 | | completed in 3 years, the
application shall be denied, the fee | 20 | | shall be forfeited, and the applicant must
reapply and meet the | 21 | | requirements in effect at the time of reapplication.
| 22 | | (Source: P.A. 90-61, eff. 12-30-97 .)
| 23 | | (225 ILCS 95/10) (from Ch. 111, par. 4610)
| 24 | | (Section scheduled to be repealed on January 1, 2018)
|
| | | 10000SB1585sam001 | - 33 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Sec. 10. Identification. No person shall use the title | 2 | | "physician or perform the
duties of
"Physician assistant" or | 3 | | perform the duties of a physician assistant unless he or she | 4 | | holds is a qualified holder of a
valid license issued by the | 5 | | Department as
provided in this Act. A physician assistant shall | 6 | | wear on his or her
person a
visible identification indicating | 7 | | that he or she is certified as a
physician
assistant while | 8 | | acting in the course of his or her duties.
| 9 | | (Source: P.A. 90-61, eff. 12-30-97 .)
| 10 | | (225 ILCS 95/11.5 new) | 11 | | Sec. 11.5. Continuing education. The Department shall | 12 | | adopt rules for continuing education for persons licensed under | 13 | | this Act that require 50 hours of continuing education per | 14 | | 2-year license renewal cycle. Completion of the 50 hours of | 15 | | continuing education shall be deemed to satisfy the continuing | 16 | | education requirements for renewal of a physician assistant | 17 | | license as required by this Act. The rules shall not be | 18 | | inconsistent with requirements of relevant national certifying | 19 | | bodies or State or national professional associations. The | 20 | | rules shall also address variances in part or in whole for good | 21 | | cause, including, but not limited to, illness or hardship. The | 22 | | continuing education rules shall ensure that licensees are | 23 | | given the opportunity to participate in programs sponsored by | 24 | | or through their State or national professional associations, | 25 | | hospitals, or other providers of continuing education. Each |
| | | 10000SB1585sam001 | - 34 - | LRB100 11277 SMS 24690 a |
|
| 1 | | licensee is responsible for maintaining records of completion | 2 | | of continuing education and shall be prepared to produce the | 3 | | records when requested by the Department.
| 4 | | (225 ILCS 95/12) (from Ch. 111, par. 4612)
| 5 | | (Section scheduled to be repealed on January 1, 2018)
| 6 | | Sec. 12. A person shall be qualified for licensure as a | 7 | | physician
assistant and the Department may issue a physician | 8 | | assistant license to a
person who:
| 9 | | 1. has Has applied in writing or electronically in form | 10 | | and substance satisfactory to the
Department and has not | 11 | | violated any of the provisions of Section 21 of this
Act or | 12 | | the rules adopted under this Act promulgated hereunder. The | 13 | | Department may take into
consideration any felony | 14 | | conviction of the applicant but such conviction
shall not | 15 | | operate as an absolute bar to licensure ;
| 16 | | 2. has Has successfully completed the examination | 17 | | provided by the National
Commission on the Certification of | 18 | | Physician Assistants Physician's Assistant or its | 19 | | successor
agency;
| 20 | | 3. holds Holds a certificate issued by the National | 21 | | Commission on the Certification of Physician Assistants or | 22 | | an equivalent successor agency; and | 23 | | 4. complies Complies with all applicable rules of the | 24 | | Department.
| 25 | | (Source: P.A. 95-703, eff. 12-31-07.)
|
| | | 10000SB1585sam001 | - 35 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (225 ILCS 95/13) (from Ch. 111, par. 4613)
| 2 | | (Section scheduled to be repealed on January 1, 2018)
| 3 | | Sec. 13. Department powers and duties. | 4 | | (a) Subject to the provisions of this Act, the Department
| 5 | | shall:
| 6 | | (1) adopt 1. Promulgate rules approved by the Board | 7 | | setting forth
standards to be met by a school or | 8 | | institution offering a course of
training for physician | 9 | | assistants prior to approval of such school
or | 10 | | institution ; .
| 11 | | (2) adopt 2. Promulgate rules approved by the Board | 12 | | setting forth
uniform and reasonable standards of | 13 | | instruction
to be met prior to approval of such course of
| 14 | | institution for physician assistants ; and .
| 15 | | (3) determine 3. Determine the reputability and good | 16 | | standing of such schools or
institutions and their course | 17 | | of instruction for physician assistants by
reference to | 18 | | compliance with such rules, provided that no school of
| 19 | | physician assistants that refuses admittance to applicants | 20 | | solely on
account of race, color, sex, or creed shall be | 21 | | considered reputable
and in good standing.
| 22 | | (b) No rule shall be adopted under this Act which allows a
| 23 | | physician assistant to perform any act, task , or function | 24 | | primarily
performed in the lawful practice of optometry under | 25 | | the Illinois
Optometric Practice Act of 1987.
|
| | | 10000SB1585sam001 | - 36 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (c) All rules shall be submitted to the Board for review | 2 | | and the Department shall consider any comments provided by the | 3 | | Board. | 4 | | (Source: P.A. 85-1440 .)
| 5 | | (225 ILCS 95/14.1)
| 6 | | (Section scheduled to be repealed on January 1, 2018)
| 7 | | Sec. 14.1. Fees.
| 8 | | (a) Fees collected for the administration of this Act shall | 9 | | be set by the
Department by rule. All fees are nonrefundable | 10 | | not refundable .
| 11 | | (b) (Blank).
| 12 | | (c) All moneys collected under this Act by the Department | 13 | | shall be
deposited in the Illinois State Medical Disciplinary | 14 | | Fund in the State
Treasury and used (1) in the exercise of its | 15 | | powers and performance of its
duties under this Act, as such | 16 | | use is made by the Department; (2) for costs
directly
related | 17 | | to licensing and license renewal of persons licensed under this | 18 | | Act; and (3) for costs related to the
public purposes of the | 19 | | Department.
| 20 | | All earnings received from investment of moneys in the | 21 | | Illinois State
Medical Disciplinary Fund shall be deposited | 22 | | into the Illinois State Medical
Disciplinary Fund and shall be | 23 | | used for the same purposes as fees deposited in
the Fund.
| 24 | | (Source: P.A. 95-703, eff. 12-31-07 .)
|
| | | 10000SB1585sam001 | - 37 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (225 ILCS 95/16) (from Ch. 111, par. 4616)
| 2 | | (Section scheduled to be repealed on January 1, 2018)
| 3 | | Sec. 16. Expiration; renewal. The expiration date and | 4 | | renewal period for
each license
issued under this Act shall be | 5 | | set by rule. Renewal shall be conditioned
on paying the | 6 | | required fee and by meeting such other requirements as may be
| 7 | | established by rule. The certification as a physician assistant | 8 | | by the National Commission on Certification of Physician | 9 | | Assistants or an equivalent successor agency is not required | 10 | | for renewal of a license under this Act.
| 11 | | Any physician assistant who has permitted his or her | 12 | | license to expire or
who
has had his or her license on inactive | 13 | | status may have the
license restored by
making application to | 14 | | the Department and filing proof acceptable to the
Department of | 15 | | his or her fitness to have the license restored,
and by paying | 16 | | the
required fees. Proof of fitness may include sworn evidence | 17 | | certifying
to active lawful practice in another jurisdiction.
| 18 | | If the physician assistant has not maintained an active | 19 | | practice in another
jurisdiction satisfactory to the | 20 | | Department,
the Department shall determine, by an evaluation | 21 | | program established by
rule, his or her fitness for restoration | 22 | | of the license and
shall establish
procedures and requirements | 23 | | for such restoration.
| 24 | | However, any physician assistant whose license expired | 25 | | while he or she
was (1)
in federal service on active duty with | 26 | | the Armed Forces of the United
States, or the State Militia |
| | | 10000SB1585sam001 | - 38 - | LRB100 11277 SMS 24690 a |
|
| 1 | | called into service or training, or (2) in
training or | 2 | | education under the supervision of the United States
| 3 | | preliminary to induction into the military service, may have | 4 | | the
license
restored without paying any lapsed renewal fees if | 5 | | within 2 years after
honorable termination of such service, | 6 | | training, or education he or she
furnishes
the Department with | 7 | | satisfactory evidence to the effect that he or she has
been so
| 8 | | engaged and that his or her service, training, or education has | 9 | | been so
terminated.
| 10 | | (Source: P.A. 90-61, eff. 12-30-97 .)
| 11 | | (225 ILCS 95/21) (from Ch. 111, par. 4621)
| 12 | | (Section scheduled to be repealed on January 1, 2018)
| 13 | | Sec. 21. Grounds for disciplinary action.
| 14 | | (a) The Department may refuse to issue or to renew, or may
| 15 | | revoke, suspend, place on probation, censure or reprimand, or | 16 | | take other
disciplinary or non-disciplinary action with regard | 17 | | to any license issued under this Act as the
Department may deem | 18 | | proper, including the issuance of fines not to exceed
$10,000
| 19 | | for each violation, for any one or combination of the following | 20 | | causes:
| 21 | | (1) Material misstatement in furnishing information to | 22 | | the Department.
| 23 | | (2) Violations of this Act, or the rules adopted under | 24 | | this Act.
| 25 | | (3) Conviction by plea of guilty or nolo contendere, |
| | | 10000SB1585sam001 | - 39 - | LRB100 11277 SMS 24690 a |
|
| 1 | | finding of guilt, jury verdict, or entry of judgment or | 2 | | sentencing, including, but not limited to, convictions, | 3 | | preceding sentences of supervision, conditional discharge, | 4 | | or first offender probation, under the laws of any | 5 | | jurisdiction of the United States that is: (i) a felony; or | 6 | | (ii) a misdemeanor, an essential element of which is | 7 | | dishonesty, or that is directly related to the practice of | 8 | | the profession. Conviction of or entry of a plea of guilty | 9 | | or nolo contendere to any crime that is a felony under the | 10 | | laws of the United States or any state or territory thereof
| 11 | | or that is a misdemeanor
of which an essential element is
| 12 | | dishonesty or
that
is directly related to the practice of | 13 | | the
profession.
| 14 | | (4) Making any misrepresentation for the purpose of | 15 | | obtaining licenses.
| 16 | | (5) Professional incompetence.
| 17 | | (6) Aiding or assisting another person in violating any | 18 | | provision of this
Act or its rules.
| 19 | | (7) Failing, within 60 days, to provide information in | 20 | | response to a
written request made by the Department.
| 21 | | (8) Engaging in dishonorable, unethical, or | 22 | | unprofessional conduct, as
defined by rule, of a character | 23 | | likely to deceive, defraud, or harm the public.
| 24 | | (9) Habitual or excessive use or addiction to alcohol, | 25 | | narcotics,
stimulants, or any other chemical agent or drug | 26 | | that results in a physician
assistant's inability to |
| | | 10000SB1585sam001 | - 40 - | LRB100 11277 SMS 24690 a |
|
| 1 | | practice with reasonable judgment, skill, or safety.
| 2 | | (10) Discipline by another U.S. jurisdiction or | 3 | | foreign nation, if at
least one of the grounds for | 4 | | discipline is the same or substantially equivalent
to those | 5 | | set forth in this Section.
| 6 | | (11) Directly or indirectly giving to or receiving from | 7 | | any person, firm,
corporation, partnership, or association | 8 | | any fee, commission, rebate or
other form of compensation | 9 | | for any professional services not actually or
personally | 10 | | rendered. Nothing in this paragraph (11) affects any bona | 11 | | fide independent contractor or employment arrangements, | 12 | | which may include provisions for compensation, health | 13 | | insurance, pension, or other employment benefits, with | 14 | | persons or entities authorized under this Act for the | 15 | | provision of services within the scope of the licensee's | 16 | | practice under this Act.
| 17 | | (12) A finding by the Disciplinary Board that the | 18 | | licensee, after having
his or her license placed on | 19 | | probationary status has violated the terms of
probation.
| 20 | | (13) Abandonment of a patient.
| 21 | | (14) Willfully making or filing false records or | 22 | | reports in his or her
practice, including but not limited | 23 | | to false records filed with state agencies
or departments.
| 24 | | (15) Willfully failing to report an instance of | 25 | | suspected child abuse or
neglect as required by the Abused | 26 | | and Neglected Child Reporting Act.
|
| | | 10000SB1585sam001 | - 41 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (16) Physical illness, or mental illness or impairment
| 2 | | that results in the inability to practice the profession | 3 | | with
reasonable judgment, skill, or safety, including, but | 4 | | not limited to, deterioration through the aging process or | 5 | | loss of motor skill.
| 6 | | (17) Being named as a perpetrator in an indicated | 7 | | report by the
Department of Children and Family Services | 8 | | under the Abused and
Neglected Child Reporting Act, and | 9 | | upon proof by clear and convincing evidence
that the | 10 | | licensee has caused a child to be an abused child or | 11 | | neglected child
as defined in the Abused and Neglected | 12 | | Child Reporting Act.
| 13 | | (18) (Blank).
| 14 | | (19) Gross negligence
resulting in permanent injury or | 15 | | death
of a patient.
| 16 | | (20) Employment of fraud, deception or any unlawful | 17 | | means in applying for
or securing a license as a physician | 18 | | assistant.
| 19 | | (21) Exceeding the authority delegated to him or her by | 20 | | his or her collaborating
supervising physician in a written | 21 | | collaborative supervision agreement.
| 22 | | (22) Immoral conduct in the commission of any act, such | 23 | | as sexual abuse,
sexual misconduct , or sexual exploitation | 24 | | related to the licensee's practice.
| 25 | | (23) Violation of the Health Care Worker Self-Referral | 26 | | Act.
|
| | | 10000SB1585sam001 | - 42 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (24) Practicing under a false or assumed name, except | 2 | | as provided by law.
| 3 | | (25) Making a false or misleading statement regarding | 4 | | his or her skill or
the efficacy or value of the medicine, | 5 | | treatment, or remedy prescribed by him
or her in the course | 6 | | of treatment.
| 7 | | (26) Allowing another person to use his or her license | 8 | | to practice.
| 9 | | (27) Prescribing, selling, administering, | 10 | | distributing, giving, or
self-administering a drug | 11 | | classified as a controlled substance (designated
product) | 12 | | or narcotic for other than medically-accepted therapeutic | 13 | | purposes.
| 14 | | (28) Promotion of the sale of drugs, devices, | 15 | | appliances, or goods
provided for a patient in a manner to | 16 | | exploit the patient for financial gain.
| 17 | | (29) A pattern of practice or other behavior that | 18 | | demonstrates incapacity
or incompetence to practice under | 19 | | this Act.
| 20 | | (30) Violating State or federal laws or regulations | 21 | | relating to controlled
substances or other legend drugs or | 22 | | ephedra as defined in the Ephedra Prohibition Act .
| 23 | | (31) Exceeding the prescriptive authority delegated by | 24 | | the collaborating
supervising physician or violating the | 25 | | written collaborative supervision agreement delegating | 26 | | that
authority.
|
| | | 10000SB1585sam001 | - 43 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (32) Practicing without providing to the Department a | 2 | | notice of collaboration
supervision or delegation of
| 3 | | prescriptive authority.
| 4 | | (33) Failure to establish and maintain records of | 5 | | patient care and treatment as required by law. | 6 | | (34) Attempting to subvert or cheat on the examination | 7 | | of the National Commission on Certification of Physician | 8 | | Assistants or its successor agency. | 9 | | (35) Willfully or negligently violating the | 10 | | confidentiality between physician assistant and patient, | 11 | | except as required by law. | 12 | | (36) Willfully failing to report an instance of | 13 | | suspected abuse, neglect, financial exploitation, or | 14 | | self-neglect of an eligible adult as defined in and | 15 | | required by the Adult Protective Services Act. | 16 | | (37) Being named as an abuser in a verified report by | 17 | | the Department on Aging under the Adult Protective Services | 18 | | Act and upon proof by clear and convincing evidence that | 19 | | the licensee abused, neglected, or financially exploited | 20 | | an eligible adult as defined in the Adult Protective | 21 | | Services Act. | 22 | | (38) Failure to report to the Department an adverse | 23 | | final action taken against him or her by another licensing | 24 | | jurisdiction of the United States or a foreign state or | 25 | | country, a peer review body, a health care institution, a | 26 | | professional society or association, a governmental |
| | | 10000SB1585sam001 | - 44 - | LRB100 11277 SMS 24690 a |
|
| 1 | | agency, a law enforcement agency, or a court acts or | 2 | | conduct similar to acts or conduct that would constitute | 3 | | grounds for action under this Section. | 4 | | (b) The Department may, without a hearing, refuse to issue | 5 | | or renew or may suspend the license of any
person who fails to | 6 | | file a return, or to pay the tax, penalty or interest
shown in | 7 | | a filed return, or to pay any final assessment of the tax,
| 8 | | penalty, or interest as required by any tax Act administered by | 9 | | the
Illinois Department of Revenue, until such time as the | 10 | | requirements of any
such tax Act are satisfied.
| 11 | | (c) The determination by a circuit court that a licensee is | 12 | | subject to
involuntary admission or judicial admission as | 13 | | provided in the Mental Health
and Developmental Disabilities | 14 | | Code operates as an automatic suspension.
The
suspension will | 15 | | end only upon a finding by a court that the patient is no
| 16 | | longer subject to involuntary admission or judicial admission | 17 | | and issues an
order so finding and discharging the patient, and | 18 | | upon the
recommendation of
the Disciplinary Board to the | 19 | | Secretary
that the licensee be allowed to resume
his or her | 20 | | practice.
| 21 | | (d) In enforcing this Section, the Department upon a | 22 | | showing of a
possible
violation may compel an individual | 23 | | licensed to practice under this Act, or
who has applied for | 24 | | licensure under this Act, to submit
to a mental or physical | 25 | | examination, or both, which may include a substance abuse or | 26 | | sexual offender evaluation, as required by and at the expense
|
| | | 10000SB1585sam001 | - 45 - | LRB100 11277 SMS 24690 a |
|
| 1 | | of the Department. | 2 | | The Department shall specifically designate the examining | 3 | | physician licensed to practice medicine in all of its branches | 4 | | or, if applicable, the multidisciplinary team involved in | 5 | | providing the mental or physical examination or both. The | 6 | | multidisciplinary team shall be led by a physician licensed to | 7 | | practice medicine in all of its branches and may consist of one | 8 | | or more or a combination of physicians licensed to practice | 9 | | medicine in all of its branches, licensed clinical | 10 | | psychologists, licensed clinical social workers, licensed | 11 | | clinical professional counselors, and other professional and | 12 | | administrative staff. Any examining physician or member of the | 13 | | multidisciplinary team may require any person ordered to submit | 14 | | to an examination pursuant to this Section to submit to any | 15 | | additional supplemental testing deemed necessary to complete | 16 | | any examination or evaluation process, including, but not | 17 | | limited to, blood testing, urinalysis, psychological testing, | 18 | | or neuropsychological testing. | 19 | | The Department may order the examining physician or any | 20 | | member of the multidisciplinary team to provide to the | 21 | | Department any and all records, including business records, | 22 | | that relate to the examination and evaluation, including any | 23 | | supplemental testing performed. | 24 | | The Department may order the examining physician or any | 25 | | member of the multidisciplinary team to
present
testimony | 26 | | concerning the mental or physical examination of the licensee |
| | | 10000SB1585sam001 | - 46 - | LRB100 11277 SMS 24690 a |
|
| 1 | | or
applicant. No information , report, record, or other | 2 | | documents in any way related to the examination shall be | 3 | | excluded by reason of any common law or
statutory privilege | 4 | | relating to communications between the licensee or
applicant | 5 | | and the examining physician or any member of the | 6 | | multidisciplinary team. No authorization is necessary from the | 7 | | licensee or applicant ordered to undergo an examination for the | 8 | | examining physician or any member of the multidisciplinary team | 9 | | to provide information, reports, records, or other documents or | 10 | | to provide any testimony regarding the examination and | 11 | | evaluation . The examining
physicians
shall be specifically | 12 | | designated by the Department. | 13 | | The individual to be examined may have, at his or her own | 14 | | expense, another
physician of his or her choice present during | 15 | | all
aspects of this examination. However, that physician shall | 16 | | be present only to observe and may not interfere in any way | 17 | | with the examination. | 18 | | Failure of an individual to submit to a mental
or
physical | 19 | | examination, when ordered directed , shall result in an | 20 | | automatic be grounds for suspension of his or
her
license until | 21 | | the individual submits to the examination if the Department
| 22 | | finds,
after notice and hearing, that the refusal to submit to | 23 | | the examination was
without reasonable cause .
| 24 | | If the Department finds an individual unable to practice | 25 | | because of
the
reasons
set forth in this Section, the | 26 | | Department may require that individual
to submit
to
care, |
| | | 10000SB1585sam001 | - 47 - | LRB100 11277 SMS 24690 a |
|
| 1 | | counseling, or treatment by physicians approved
or designated | 2 | | by the Department, as a condition, term, or restriction
for | 3 | | continued,
reinstated, or
renewed licensure to practice; or, in | 4 | | lieu of care, counseling, or treatment,
the Department may file
| 5 | | a complaint to immediately
suspend, revoke, or otherwise | 6 | | discipline the license of the individual.
An individual whose
| 7 | | license was granted, continued, reinstated, renewed, | 8 | | disciplined, or supervised
subject to such terms, conditions, | 9 | | or restrictions, and who fails to comply
with
such terms, | 10 | | conditions, or restrictions, shall be referred to the Secretary
| 11 | | for
a
determination as to whether the individual shall have his | 12 | | or her license
suspended immediately, pending a hearing by the | 13 | | Department.
| 14 | | In instances in which the Secretary
immediately suspends a | 15 | | person's license
under this Section, a hearing on that person's | 16 | | license must be convened by
the Department within 30
days after | 17 | | the suspension and completed without
appreciable
delay.
The | 18 | | Department shall have the authority to review the subject
| 19 | | individual's record of
treatment and counseling regarding the | 20 | | impairment to the extent permitted by
applicable federal | 21 | | statutes and regulations safeguarding the confidentiality of
| 22 | | medical records.
| 23 | | An individual licensed under this Act and affected under | 24 | | this Section shall
be
afforded an opportunity to demonstrate to | 25 | | the Department that he or
she can resume
practice in compliance | 26 | | with acceptable and prevailing standards under the
provisions |
| | | 10000SB1585sam001 | - 48 - | LRB100 11277 SMS 24690 a |
|
| 1 | | of his or her license.
| 2 | | (e) An individual or organization acting in good faith, and | 3 | | not in a willful and wanton manner, in complying with this | 4 | | Section by providing a report or other information to the | 5 | | Board, by assisting in the investigation or preparation of a | 6 | | report or information, by participating in proceedings of the | 7 | | Board, or by serving as a member of the Board, shall not be | 8 | | subject to criminal prosecution or civil damages as a result of | 9 | | such actions. | 10 | | (f) Members of the Board and the Disciplinary Board shall | 11 | | be indemnified by the State for any actions occurring within | 12 | | the scope of services on the Disciplinary Board or Board, done | 13 | | in good faith and not willful and wanton in nature. The | 14 | | Attorney General shall defend all such actions unless he or she | 15 | | determines either that there would be a conflict of interest in | 16 | | such representation or that the actions complained of were not | 17 | | in good faith or were willful and wanton. | 18 | | If the Attorney General declines representation, the | 19 | | member has the right to employ counsel of his or her choice, | 20 | | whose fees shall be provided by the State, after approval by | 21 | | the Attorney General, unless there is a determination by a | 22 | | court that the member's actions were not in good faith or were | 23 | | willful and wanton. | 24 | | The member must notify the Attorney General within 7 days | 25 | | after receipt of notice of the initiation of any action | 26 | | involving services of the Disciplinary Board. Failure to so |
| | | 10000SB1585sam001 | - 49 - | LRB100 11277 SMS 24690 a |
|
| 1 | | notify the Attorney General constitutes an absolute waiver of | 2 | | the right to a defense and indemnification. | 3 | | The Attorney General shall determine, within 7 days after | 4 | | receiving such notice, whether he or she will undertake to | 5 | | represent the member. | 6 | | (Source: P.A. 95-703, eff. 12-31-07; 96-268, eff. 8-11-09; | 7 | | 96-1482, eff. 11-29-10.)
| 8 | | (225 ILCS 95/22.2) (from Ch. 111, par. 4622.2)
| 9 | | (Section scheduled to be repealed on January 1, 2018)
| 10 | | Sec. 22.2. Investigation; notice; hearing. The Department | 11 | | may investigate
the actions of any applicant
or of any person | 12 | | or persons holding or claiming to hold a license. The
| 13 | | Department shall, before suspending, revoking, placing on | 14 | | probationary
status, or taking any other disciplinary action as | 15 | | the Department may deem
proper with regard to any license, at | 16 | | least 30 days prior to
the date set for the hearing, notify the | 17 | | applicant or licensee
in writing of any charges
made and the | 18 | | time and place for a hearing of the charges before the
| 19 | | Disciplinary Board, direct him or her to file his or her | 20 | | written answer
thereto to the
Disciplinary Board under oath | 21 | | within 20 days after the service on him or
her of
such notice | 22 | | and inform him or her that if he or she fails to file such
| 23 | | answer default
will be taken against him or her and his or her
| 24 | | license may be suspended, revoked, placed on probationary
| 25 | | status, or have other disciplinary action, including limiting |
| | | 10000SB1585sam001 | - 50 - | LRB100 11277 SMS 24690 a |
|
| 1 | | the scope,
nature or extent of his or her practice, as the | 2 | | Department may deem proper
taken
with regard thereto. Written | 3 | | or electronic
notice may be served by personal
delivery , email, | 4 | | or certified or registered mail to the applicant or licensee at | 5 | | his or her last address of record or email address of record | 6 | | with the Department . At the time and place fixed in the notice,
| 7 | | the Department shall proceed to hear the charges and the | 8 | | parties or their
counsel shall be accorded ample opportunity to | 9 | | present such statements,
testimony, evidence, and argument as | 10 | | may be pertinent to the charges or to
the defense thereto. The | 11 | | Department may continue such hearing from time to
time. In case | 12 | | the applicant or licensee, after receiving
notice, fails to | 13 | | file an
answer, his or her license may in the discretion of the | 14 | | Secretary,
having received first the recommendation of the | 15 | | Disciplinary Board, be
suspended, revoked, placed on | 16 | | probationary status, or the Secretary
may take
whatever | 17 | | disciplinary action as he or she may deem proper, including
| 18 | | limiting the
scope, nature, or extent of such person's | 19 | | practice, without a hearing, if
the act or acts charged | 20 | | constitute sufficient grounds for such action
under this Act.
| 21 | | (Source: P.A. 95-703, eff. 12-31-07.)
| 22 | | (225 ILCS 95/22.6) (from Ch. 111, par. 4622.6)
| 23 | | (Section scheduled to be repealed on January 1, 2018)
| 24 | | Sec. 22.6. At the conclusion of the hearing , the | 25 | | Disciplinary Board shall
present to the Secretary
a written |
| | | 10000SB1585sam001 | - 51 - | LRB100 11277 SMS 24690 a |
|
| 1 | | report of its findings of fact,
conclusions of law , and | 2 | | recommendations. The report shall contain a finding
whether or | 3 | | not the accused person violated this Act or failed to comply
| 4 | | with the conditions required in this Act. The Disciplinary | 5 | | Board shall
specify the nature of the violation or failure to | 6 | | comply, and shall make
its recommendations to the Secretary.
| 7 | | The report of findings of fact, conclusions of law , and | 8 | | recommendation of
the Disciplinary Board shall be the basis for | 9 | | the Department's order or
refusal or for the granting of a | 10 | | license or permit. If the Secretary
disagrees in any regard | 11 | | with the report of the Disciplinary Board, the Secretary
may | 12 | | issue an order in contravention thereof. The Secretary
shall
| 13 | | provide a written report to the Disciplinary Board on any | 14 | | deviation, and
shall specify with particularity the reasons
for | 15 | | such action in the final order. The finding is not admissible | 16 | | in
evidence against the person in a criminal prosecution | 17 | | brought for the
violation of this Act, but the hearing and | 18 | | finding are not a bar to a
criminal prosecution brought for the | 19 | | violation of this Act.
| 20 | | (Source: P.A. 95-703, eff. 12-31-07.)
| 21 | | (225 ILCS 95/22.7) (from Ch. 111, par. 4622.7)
| 22 | | (Section scheduled to be repealed on January 1, 2018)
| 23 | | Sec. 22.7. Hearing officer. Notwithstanding the provisions | 24 | | of Section
22.2 of this
Act, the Secretary
shall have the | 25 | | authority to appoint any attorney duly
licensed to practice law |
| | | 10000SB1585sam001 | - 52 - | LRB100 11277 SMS 24690 a |
|
| 1 | | in the State of Illinois to serve as the hearing
officer in any | 2 | | action for refusal to issue or renew, or for
discipline of, a | 3 | | license. The Secretary
shall notify the Disciplinary Board of
| 4 | | any
such
appointment. The hearing officer shall have full | 5 | | authority to conduct the
hearing. The hearing officer shall | 6 | | report his or her findings of fact,
conclusions of law, and | 7 | | recommendations to the Disciplinary Board and the Secretary. | 8 | | The Disciplinary Board shall have 60 days from receipt of the
| 9 | | report to review the report of the hearing officer and present | 10 | | their
findings of fact, conclusions of law, and recommendations | 11 | | to the Secretary.
If the Disciplinary Board fails to present | 12 | | its report within the 60-day 60 day
period, the respondent may | 13 | | request in writing a direct appeal to the Secretary, in which | 14 | | case the Secretary may shall, within 7 calendar days after the | 15 | | request, issue an order directing the Disciplinary Board to | 16 | | issue its findings of fact, conclusions of law, and | 17 | | recommendations to the Secretary within 30 calendar days after | 18 | | such order. If the Disciplinary Board fails to issue its | 19 | | findings of fact, conclusions of law, and recommendations | 20 | | within that time frame to the Secretary after the entry of such | 21 | | order, the Secretary shall, within 30 calendar days thereafter, | 22 | | issue an order based upon the report of the hearing officer and | 23 | | the record of the proceedings or issue an order remanding the | 24 | | matter back to the hearing officer for additional proceedings | 25 | | in accordance with the order. If (i) a direct appeal is | 26 | | requested, (ii) the Disciplinary Board fails to issue its |
| | | 10000SB1585sam001 | - 53 - | LRB100 11277 SMS 24690 a |
|
| 1 | | findings of fact, conclusions of law, and recommendations | 2 | | within the 30-day mandate from the Secretary or the Secretary | 3 | | fails to order the Disciplinary Board to do so, and (iii) the | 4 | | Secretary fails to issue an order within 30 calendar days | 5 | | thereafter, then the hearing officer's report is deemed | 6 | | accepted and a final decision of the Secretary. Notwithstanding | 7 | | any other provision of this Section, if the Secretary, upon | 8 | | review, determines that substantial justice has not been done | 9 | | in the revocation, suspension, or refusal to issue or renew a | 10 | | license or other disciplinary action taken as the result of the | 11 | | entry of the hearing officer's report, the Secretary may order | 12 | | a rehearing by the same or other examiners. If the Secretary
| 13 | | disagrees in any regard with the report
of the Disciplinary | 14 | | Board or hearing officer, he or she may issue an order
in
| 15 | | contravention thereof. The Secretary
shall provide a written | 16 | | explanation to
the Disciplinary Board on any such deviation, | 17 | | and shall specify with
particularity the reasons for such | 18 | | action in the final order.
| 19 | | (Source: P.A. 95-703, eff. 12-31-07.)
| 20 | | (225 ILCS 95/22.11) (from Ch. 111, par. 4622.11)
| 21 | | (Section scheduled to be repealed on January 1, 2018)
| 22 | | Sec. 22.11. Restoration of license. At any time after the | 23 | | successful completion of a term of probation, suspension , or
| 24 | | revocation of any
license , the Department may restore it to the | 25 | | licensee,
unless after
an investigation and a hearing, the |
| | | 10000SB1585sam001 | - 54 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Department determines that restoration
is not in the public | 2 | | interest.
Where circumstances of suspension or revocation so | 3 | | indicate, the Department
may require an examination of the | 4 | | licensee prior to restoring his or her
license. No person whose | 5 | | license has been revoked as authorized in this Act may apply | 6 | | for restoration of that license until such time as provided for | 7 | | in the Civil Administrative Code of Illinois.
| 8 | | A license that has been suspended or revoked shall be | 9 | | considered nonrenewed for purposes of restoration and a person | 10 | | restoring his or her license from suspension or revocation must | 11 | | comply with the requirements for restoration of a nonrenewed | 12 | | license as set forth in Section 16 of this Act and any related | 13 | | rules adopted. | 14 | | (Source: P.A. 90-61, eff. 12-30-97 .)
| 15 | | (225 ILCS 95/22.14) (from Ch. 111, par. 4622.14)
| 16 | | (Section scheduled to be repealed on January 1, 2018)
| 17 | | Sec. 22.14. Administrative review; certification of | 18 | | record. | 19 | | (a) All final administrative decisions of the Department | 20 | | are
subject to judicial review pursuant to the provisions of | 21 | | the " Administrative
Review Law " , and all rules adopted pursuant | 22 | | thereto. The term
"administrative decision" is defined as in | 23 | | Section 3-101 of the " Code
of Civil Procedure " .
| 24 | | (b) Proceedings for judicial review shall be commenced in | 25 | | the circuit court
of the county in which the party applying for |
| | | 10000SB1585sam001 | - 55 - | LRB100 11277 SMS 24690 a |
|
| 1 | | review resides; but if the
party is not a resident of this | 2 | | State, venue shall be in Sangamon
County.
| 3 | | (c) The Department shall not be required to certify any | 4 | | record to the court, to file an answer in court, or to | 5 | | otherwise appear in any court in a judicial review proceeding | 6 | | unless and until the Department has received from the plaintiff | 7 | | payment of the costs of furnishing and certifying the record, | 8 | | which costs shall be determined by the Department. Exhibits | 9 | | shall be certified without cost. Failure on the part of the | 10 | | plaintiff to file a receipt in court is grounds for dismissal | 11 | | of the action. During the pendency and hearing of any and all | 12 | | judicial proceedings incident to the disciplinary action the | 13 | | sanctions imposed upon the accused by the Department because of | 14 | | acts or omissions related to the delivery of direct patient | 15 | | care as specified in the Department's final administrative | 16 | | decision, shall, as a matter of public policy, remain in full | 17 | | force and effect in order to protect the public pending final | 18 | | resolution of any of the proceedings. | 19 | | (Source: P.A. 86-596 .)
| 20 | | (225 ILCS 95/22.17 new) | 21 | | Sec. 22.17. Confidentiality. All information collected by | 22 | | the Department in the course of an examination or investigation | 23 | | of a licensee or applicant, including, but not limited to, any | 24 | | complaint against a licensee filed with the Department and | 25 | | information collected to investigate any such complaint, shall |
| | | 10000SB1585sam001 | - 56 - | LRB100 11277 SMS 24690 a |
|
| 1 | | be maintained for the confidential use of the Department and | 2 | | shall not be disclosed. The Department shall not disclose the | 3 | | information to anyone other than law enforcement officials, | 4 | | regulatory agencies that have an appropriate regulatory | 5 | | interest as determined by the Secretary, or a party presenting | 6 | | a lawful subpoena to the Department. Information and documents | 7 | | disclosed to a federal, State, county, or local law enforcement | 8 | | agency shall not be disclosed by the agency for any purpose to | 9 | | any other agency or person. A formal complaint filed against a | 10 | | licensee by the Department or any order issued by the | 11 | | Department against a licensee or applicant shall be a public | 12 | | record, except as otherwise prohibited by law.
| 13 | | (225 ILCS 95/23) (from Ch. 111, par. 4623)
| 14 | | (Section scheduled to be repealed on January 1, 2018)
| 15 | | Sec. 23. Home rule. It is declared to be the public policy | 16 | | of this State,
pursuant to paragraphs (h) and (i) of Section 6 | 17 | | of Article VII of the
Illinois Constitution of 1970, that any | 18 | | power or function set forth in this
Act to be exercised by the | 19 | | State is an exclusive State power or function.
Such power or | 20 | | function shall not be exercised concurrently, either directly
| 21 | | or indirectly, by any unit of local government, including home | 22 | | rule units,
except as otherwise provided in this Act.
| 23 | | (Source: P.A. 85-981 .)
| 24 | | Section 15. The Illinois Public Aid Code is amended by |
| | | 10000SB1585sam001 | - 57 - | LRB100 11277 SMS 24690 a |
|
| 1 | | changing Section 5-8 as follows: | 2 | | (305 ILCS 5/5-8) (from Ch. 23, par. 5-8)
| 3 | | Sec. 5-8. Practitioners. In supplying medical assistance, | 4 | | the Illinois
Department may provide for the legally authorized | 5 | | services of (i) persons
licensed under the Medical Practice Act | 6 | | of 1987, as amended, except as
hereafter in this Section | 7 | | stated, whether under a
general or limited license, (ii) | 8 | | persons licensed under the Nurse Practice Act as advanced | 9 | | practice nurses, regardless of whether or not the persons have | 10 | | written collaborative agreements, (iii) persons licensed or | 11 | | registered
under
other laws of this State to provide dental, | 12 | | medical, pharmaceutical,
optometric, podiatric, or nursing | 13 | | services, or other remedial care
recognized under State law, | 14 | | and (iv) persons licensed under other laws of
this State as a | 15 | | clinical social worker , and (v) persons licensed under other | 16 | | laws of this State as physician assistants . The Department | 17 | | shall adopt rules, no later than 90 days after the effective | 18 | | date of this amendatory Act of the 99th General Assembly, for | 19 | | the legally authorized services of persons licensed under other | 20 | | laws of this State as a clinical social worker.
The Department | 21 | | may not provide for legally
authorized services of any | 22 | | physician who has been convicted of having performed
an | 23 | | abortion procedure in a wilful and wanton manner on a woman who | 24 | | was not
pregnant at the time such abortion procedure was | 25 | | performed. The
utilization of the services of persons engaged |
| | | 10000SB1585sam001 | - 58 - | LRB100 11277 SMS 24690 a |
|
| 1 | | in the treatment or care of
the sick, which persons are not | 2 | | required to be licensed or registered under
the laws of this | 3 | | State, is not prohibited by this Section.
| 4 | | (Source: P.A. 99-173, eff. 7-29-15; 99-621, eff. 1-1-17 .)
| 5 | | Section 20. The Illinois Controlled Substances Act is | 6 | | amended by changing Sections 102 and 303.05 as follows: | 7 | | (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | 8 | | Sec. 102. Definitions. As used in this Act, unless the | 9 | | context
otherwise requires:
| 10 | | (a) "Addict" means any person who habitually uses any drug, | 11 | | chemical,
substance or dangerous drug other than alcohol so as | 12 | | to endanger the public
morals, health, safety or welfare or who | 13 | | is so far addicted to the use of a
dangerous drug or controlled | 14 | | substance other than alcohol as to have lost
the power of self | 15 | | control with reference to his or her addiction.
| 16 | | (b) "Administer" means the direct application of a | 17 | | controlled
substance, whether by injection, inhalation, | 18 | | ingestion, or any other
means, to the body of a patient, | 19 | | research subject, or animal (as
defined by the Humane | 20 | | Euthanasia in Animal Shelters Act) by:
| 21 | | (1) a practitioner (or, in his or her presence, by his | 22 | | or her authorized agent),
| 23 | | (2) the patient or research subject pursuant to an | 24 | | order, or
|
| | | 10000SB1585sam001 | - 59 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (3) a euthanasia technician as defined by the Humane | 2 | | Euthanasia in
Animal Shelters Act.
| 3 | | (c) "Agent" means an authorized person who acts on behalf | 4 | | of or at
the direction of a manufacturer, distributor, | 5 | | dispenser, prescriber, or practitioner. It does not
include a | 6 | | common or contract carrier, public warehouseman or employee of
| 7 | | the carrier or warehouseman.
| 8 | | (c-1) "Anabolic Steroids" means any drug or hormonal | 9 | | substance,
chemically and pharmacologically related to | 10 | | testosterone (other than
estrogens, progestins, | 11 | | corticosteroids, and dehydroepiandrosterone),
and includes:
| 12 | | (i) 3[beta],17-dihydroxy-5a-androstane, | 13 | | (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, | 14 | | (iii) 5[alpha]-androstan-3,17-dione, | 15 | | (iv) 1-androstenediol (3[beta], | 16 | | 17[beta]-dihydroxy-5[alpha]-androst-1-ene), | 17 | | (v) 1-androstenediol (3[alpha], | 18 | | 17[beta]-dihydroxy-5[alpha]-androst-1-ene), | 19 | | (vi) 4-androstenediol | 20 | | (3[beta],17[beta]-dihydroxy-androst-4-ene), | 21 | | (vii) 5-androstenediol | 22 | | (3[beta],17[beta]-dihydroxy-androst-5-ene), | 23 | | (viii) 1-androstenedione | 24 | | ([5alpha]-androst-1-en-3,17-dione), | 25 | | (ix) 4-androstenedione | 26 | | (androst-4-en-3,17-dione), |
| | | 10000SB1585sam001 | - 60 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (x) 5-androstenedione | 2 | | (androst-5-en-3,17-dione), | 3 | | (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- | 4 | | hydroxyandrost-4-en-3-one), | 5 | | (xii) boldenone (17[beta]-hydroxyandrost- | 6 | | 1,4,-diene-3-one), | 7 | | (xiii) boldione (androsta-1,4- | 8 | | diene-3,17-dione), | 9 | | (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 | 10 | | [beta]-hydroxyandrost-4-en-3-one), | 11 | | (xv) clostebol (4-chloro-17[beta]- | 12 | | hydroxyandrost-4-en-3-one), | 13 | | (xvi) dehydrochloromethyltestosterone (4-chloro- | 14 | | 17[beta]-hydroxy-17[alpha]-methyl- | 15 | | androst-1,4-dien-3-one), | 16 | | (xvii) desoxymethyltestosterone | 17 | | (17[alpha]-methyl-5[alpha] | 18 | | -androst-2-en-17[beta]-ol)(a.k.a., madol), | 19 | | (xviii) [delta]1-dihydrotestosterone (a.k.a. | 20 | | '1-testosterone') (17[beta]-hydroxy- | 21 | | 5[alpha]-androst-1-en-3-one), | 22 | | (xix) 4-dihydrotestosterone (17[beta]-hydroxy- | 23 | | androstan-3-one), | 24 | | (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- | 25 | | 5[alpha]-androstan-3-one), | 26 | | (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- |
| | | 10000SB1585sam001 | - 61 - | LRB100 11277 SMS 24690 a |
|
| 1 | | hydroxyestr-4-ene), | 2 | | (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- | 3 | | 1[beta],17[beta]-dihydroxyandrost-4-en-3-one), | 4 | | (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], | 5 | | 17[beta]-dihydroxyandrost-1,4-dien-3-one), | 6 | | (xxiv) furazabol (17[alpha]-methyl-17[beta]- | 7 | | hydroxyandrostano[2,3-c]-furazan), | 8 | | (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one) | 9 | | (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- | 10 | | androst-4-en-3-one), | 11 | | (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- | 12 | | dihydroxy-estr-4-en-3-one), | 13 | | (xxviii) mestanolone (17[alpha]-methyl-17[beta]- | 14 | | hydroxy-5-androstan-3-one), | 15 | | (xxix) mesterolone (1amethyl-17[beta]-hydroxy- | 16 | | [5a]-androstan-3-one), | 17 | | (xxx) methandienone (17[alpha]-methyl-17[beta]- | 18 | | hydroxyandrost-1,4-dien-3-one), | 19 | | (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- | 20 | | dihydroxyandrost-5-ene), | 21 | | (xxxii) methenolone (1-methyl-17[beta]-hydroxy- | 22 | | 5[alpha]-androst-1-en-3-one), | 23 | | (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- | 24 | | dihydroxy-5a-androstane), | 25 | | (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy | 26 | | -5a-androstane), |
| | | 10000SB1585sam001 | - 62 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (xxxv) 17[alpha]-methyl-3[beta],17[beta]- | 2 | | dihydroxyandrost-4-ene), | 3 | | (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- | 4 | | methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), | 5 | | (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- | 6 | | hydroxyestra-4,9(10)-dien-3-one), | 7 | | (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- | 8 | | hydroxyestra-4,9-11-trien-3-one), | 9 | | (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- | 10 | | hydroxyandrost-4-en-3-one), | 11 | | (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- | 12 | | hydroxyestr-4-en-3-one), | 13 | | (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone | 14 | | (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- | 15 | | androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- | 16 | | 1-testosterone'), | 17 | | (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), | 18 | | (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- | 19 | | dihydroxyestr-4-ene), | 20 | | (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- | 21 | | dihydroxyestr-4-ene), | 22 | | (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- | 23 | | dihydroxyestr-5-ene), | 24 | | (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- | 25 | | dihydroxyestr-5-ene), | 26 | | (xlvii) 19-nor-4,9(10)-androstadienedione |
| | | 10000SB1585sam001 | - 63 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (estra-4,9(10)-diene-3,17-dione), | 2 | | (xlviii) 19-nor-4-androstenedione (estr-4- | 3 | | en-3,17-dione), | 4 | | (xlix) 19-nor-5-androstenedione (estr-5- | 5 | | en-3,17-dione), | 6 | | (l) norbolethone (13[beta], 17a-diethyl-17[beta]- | 7 | | hydroxygon-4-en-3-one), | 8 | | (li) norclostebol (4-chloro-17[beta]- | 9 | | hydroxyestr-4-en-3-one), | 10 | | (lii) norethandrolone (17[alpha]-ethyl-17[beta]- | 11 | | hydroxyestr-4-en-3-one), | 12 | | (liii) normethandrolone (17[alpha]-methyl-17[beta]- | 13 | | hydroxyestr-4-en-3-one), | 14 | | (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- | 15 | | 2-oxa-5[alpha]-androstan-3-one), | 16 | | (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- | 17 | | dihydroxyandrost-4-en-3-one), | 18 | | (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- | 19 | | 17[beta]-hydroxy-(5[alpha]-androstan-3-one), | 20 | | (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- | 21 | | (5[alpha]-androst-2-eno[3,2-c]-pyrazole), | 22 | | (lviii) stenbolone (17[beta]-hydroxy-2-methyl- | 23 | | (5[alpha]-androst-1-en-3-one), | 24 | | (lix) testolactone (13-hydroxy-3-oxo-13,17- | 25 | | secoandrosta-1,4-dien-17-oic | 26 | | acid lactone), |
| | | 10000SB1585sam001 | - 64 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (lx) testosterone (17[beta]-hydroxyandrost- | 2 | | 4-en-3-one), | 3 | | (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- | 4 | | diethyl-17[beta]-hydroxygon- | 5 | | 4,9,11-trien-3-one), | 6 | | (lxii) trenbolone (17[beta]-hydroxyestr-4,9, | 7 | | 11-trien-3-one).
| 8 | | Any person who is otherwise lawfully in possession of an | 9 | | anabolic
steroid, or who otherwise lawfully manufactures, | 10 | | distributes, dispenses,
delivers, or possesses with intent to | 11 | | deliver an anabolic steroid, which
anabolic steroid is | 12 | | expressly intended for and lawfully allowed to be
administered | 13 | | through implants to livestock or other nonhuman species, and
| 14 | | which is approved by the Secretary of Health and Human Services | 15 | | for such
administration, and which the person intends to | 16 | | administer or have
administered through such implants, shall | 17 | | not be considered to be in
unauthorized possession or to | 18 | | unlawfully manufacture, distribute, dispense,
deliver, or | 19 | | possess with intent to deliver such anabolic steroid for
| 20 | | purposes of this Act.
| 21 | | (d) "Administration" means the Drug Enforcement | 22 | | Administration,
United States Department of Justice, or its | 23 | | successor agency.
| 24 | | (d-5) "Clinical Director, Prescription Monitoring Program" | 25 | | means a Department of Human Services administrative employee | 26 | | licensed to either prescribe or dispense controlled substances |
| | | 10000SB1585sam001 | - 65 - | LRB100 11277 SMS 24690 a |
|
| 1 | | who shall run the clinical aspects of the Department of Human | 2 | | Services Prescription Monitoring Program and its Prescription | 3 | | Information Library. | 4 | | (d-10) "Compounding" means the preparation and mixing of | 5 | | components, excluding flavorings, (1) as the result of a | 6 | | prescriber's prescription drug order or initiative based on the | 7 | | prescriber-patient-pharmacist relationship in the course of | 8 | | professional practice or (2) for the purpose of, or incident | 9 | | to, research, teaching, or chemical analysis and not for sale | 10 | | or dispensing. "Compounding" includes the preparation of drugs | 11 | | or devices in anticipation of receiving prescription drug | 12 | | orders based on routine, regularly observed dispensing | 13 | | patterns. Commercially available products may be compounded | 14 | | for dispensing to individual patients only if both of the | 15 | | following conditions are met: (i) the commercial product is not | 16 | | reasonably available from normal distribution channels in a | 17 | | timely manner to meet the patient's needs and (ii) the | 18 | | prescribing practitioner has requested that the drug be | 19 | | compounded. | 20 | | (e) "Control" means to add a drug or other substance, or | 21 | | immediate
precursor, to a Schedule whether by
transfer from | 22 | | another Schedule or otherwise.
| 23 | | (f) "Controlled Substance" means (i) a drug, substance, | 24 | | immediate
precursor, or synthetic drug in the Schedules of | 25 | | Article II of this Act or (ii) a drug or other substance, or | 26 | | immediate precursor, designated as a controlled substance by |
| | | 10000SB1585sam001 | - 66 - | LRB100 11277 SMS 24690 a |
|
| 1 | | the Department through administrative rule. The term does not | 2 | | include distilled spirits, wine, malt beverages, or tobacco, as | 3 | | those terms are
defined or used in the Liquor Control Act of | 4 | | 1934 and the Tobacco Products Tax
Act of 1995.
| 5 | | (f-5) "Controlled substance analog" means a substance: | 6 | | (1) the chemical structure of which is substantially | 7 | | similar to the chemical structure of a controlled substance | 8 | | in Schedule I or II; | 9 | | (2) which has a stimulant, depressant, or | 10 | | hallucinogenic effect on the central nervous system that is | 11 | | substantially similar to or greater than the stimulant, | 12 | | depressant, or hallucinogenic effect on the central | 13 | | nervous system of a controlled substance in Schedule I or | 14 | | II; or | 15 | | (3) with respect to a particular person, which such | 16 | | person represents or intends to have a stimulant, | 17 | | depressant, or hallucinogenic effect on the central | 18 | | nervous system that is substantially similar to or greater | 19 | | than the stimulant, depressant, or hallucinogenic effect | 20 | | on the central nervous system of a controlled substance in | 21 | | Schedule I or II. | 22 | | (g) "Counterfeit substance" means a controlled substance, | 23 | | which, or
the container or labeling of which, without | 24 | | authorization bears the
trademark, trade name, or other | 25 | | identifying mark, imprint, number or
device, or any likeness | 26 | | thereof, of a manufacturer, distributor, or
dispenser other |
| | | 10000SB1585sam001 | - 67 - | LRB100 11277 SMS 24690 a |
|
| 1 | | than the person who in fact manufactured, distributed,
or | 2 | | dispensed the substance.
| 3 | | (h) "Deliver" or "delivery" means the actual, constructive | 4 | | or
attempted transfer of possession of a controlled substance, | 5 | | with or
without consideration, whether or not there is an | 6 | | agency relationship.
| 7 | | (i) "Department" means the Illinois Department of Human | 8 | | Services (as
successor to the Department of Alcoholism and | 9 | | Substance Abuse) or its successor agency.
| 10 | | (j) (Blank).
| 11 | | (k) "Department of Corrections" means the Department of | 12 | | Corrections
of the State of Illinois or its successor agency.
| 13 | | (l) "Department of Financial and Professional Regulation" | 14 | | means the Department
of Financial and Professional Regulation | 15 | | of the State of Illinois or its successor agency.
| 16 | | (m) "Depressant" means any drug that (i) causes an overall | 17 | | depression of central nervous system functions, (ii) causes | 18 | | impaired consciousness and awareness, and (iii) can be | 19 | | habit-forming or lead to a substance abuse problem, including | 20 | | but not limited to alcohol, cannabis and its active principles | 21 | | and their analogs, benzodiazepines and their analogs, | 22 | | barbiturates and their analogs, opioids (natural and | 23 | | synthetic) and their analogs, and chloral hydrate and similar | 24 | | sedative hypnotics.
| 25 | | (n) (Blank).
| 26 | | (o) "Director" means the Director of the Illinois State |
| | | 10000SB1585sam001 | - 68 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Police or his or her designated agents.
| 2 | | (p) "Dispense" means to deliver a controlled substance to | 3 | | an
ultimate user or research subject by or pursuant to the | 4 | | lawful order of
a prescriber, including the prescribing, | 5 | | administering, packaging,
labeling, or compounding necessary | 6 | | to prepare the substance for that
delivery.
| 7 | | (q) "Dispenser" means a practitioner who dispenses.
| 8 | | (r) "Distribute" means to deliver, other than by | 9 | | administering or
dispensing, a controlled substance.
| 10 | | (s) "Distributor" means a person who distributes.
| 11 | | (t) "Drug" means (1) substances recognized as drugs in the | 12 | | official
United States Pharmacopoeia, Official Homeopathic | 13 | | Pharmacopoeia of the
United States, or official National | 14 | | Formulary, or any supplement to any
of them; (2) substances | 15 | | intended for use in diagnosis, cure, mitigation,
treatment, or | 16 | | prevention of disease in man or animals; (3) substances
(other | 17 | | than food) intended to affect the structure of any function of
| 18 | | the body of man or animals and (4) substances intended for use | 19 | | as a
component of any article specified in clause (1), (2), or | 20 | | (3) of this
subsection. It does not include devices or their | 21 | | components, parts, or
accessories.
| 22 | | (t-3) "Electronic health record" or "EHR" means an | 23 | | electronic record of health-related information on an | 24 | | individual that is created, gathered, managed, and consulted by | 25 | | authorized health care clinicians and staff. | 26 | | (t-5) "Euthanasia agency" means
an entity certified by the |
| | | 10000SB1585sam001 | - 69 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Department of Financial and Professional Regulation for the
| 2 | | purpose of animal euthanasia that holds an animal control | 3 | | facility license or
animal
shelter license under the Animal | 4 | | Welfare Act. A euthanasia agency is
authorized to purchase, | 5 | | store, possess, and utilize Schedule II nonnarcotic and
| 6 | | Schedule III nonnarcotic drugs for the sole purpose of animal | 7 | | euthanasia.
| 8 | | (t-10) "Euthanasia drugs" means Schedule II or Schedule III | 9 | | substances
(nonnarcotic controlled substances) that are used | 10 | | by a euthanasia agency for
the purpose of animal euthanasia.
| 11 | | (u) "Good faith" means the prescribing or dispensing of a | 12 | | controlled
substance by a practitioner in the regular course of | 13 | | professional
treatment to or for any person who is under his or | 14 | | her treatment for a
pathology or condition other than that | 15 | | individual's physical or
psychological dependence upon or | 16 | | addiction to a controlled substance,
except as provided herein: | 17 | | and application of the term to a pharmacist
shall mean the | 18 | | dispensing of a controlled substance pursuant to the
| 19 | | prescriber's order which in the professional judgment of the | 20 | | pharmacist
is lawful. The pharmacist shall be guided by | 21 | | accepted professional
standards including, but not limited to | 22 | | the following, in making the
judgment:
| 23 | | (1) lack of consistency of prescriber-patient | 24 | | relationship,
| 25 | | (2) frequency of prescriptions for same drug by one | 26 | | prescriber for
large numbers of patients,
|
| | | 10000SB1585sam001 | - 70 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (3) quantities beyond those normally prescribed,
| 2 | | (4) unusual dosages (recognizing that there may be | 3 | | clinical circumstances where more or less than the usual | 4 | | dose may be used legitimately),
| 5 | | (5) unusual geographic distances between patient, | 6 | | pharmacist and
prescriber,
| 7 | | (6) consistent prescribing of habit-forming drugs.
| 8 | | (u-0.5) "Hallucinogen" means a drug that causes markedly | 9 | | altered sensory perception leading to hallucinations of any | 10 | | type. | 11 | | (u-1) "Home infusion services" means services provided by a | 12 | | pharmacy in
compounding solutions for direct administration to | 13 | | a patient in a private
residence, long-term care facility, or | 14 | | hospice setting by means of parenteral,
intravenous, | 15 | | intramuscular, subcutaneous, or intraspinal infusion.
| 16 | | (u-5) "Illinois State Police" means the State
Police of the | 17 | | State of Illinois, or its successor agency. | 18 | | (v) "Immediate precursor" means a substance:
| 19 | | (1) which the Department has found to be and by rule | 20 | | designated as
being a principal compound used, or produced | 21 | | primarily for use, in the
manufacture of a controlled | 22 | | substance;
| 23 | | (2) which is an immediate chemical intermediary used or | 24 | | likely to
be used in the manufacture of such controlled | 25 | | substance; and
| 26 | | (3) the control of which is necessary to prevent, |
| | | 10000SB1585sam001 | - 71 - | LRB100 11277 SMS 24690 a |
|
| 1 | | curtail or limit
the manufacture of such controlled | 2 | | substance.
| 3 | | (w) "Instructional activities" means the acts of teaching, | 4 | | educating
or instructing by practitioners using controlled | 5 | | substances within
educational facilities approved by the State | 6 | | Board of Education or
its successor agency.
| 7 | | (x) "Local authorities" means a duly organized State, | 8 | | County or
Municipal peace unit or police force.
| 9 | | (y) "Look-alike substance" means a substance, other than a | 10 | | controlled
substance which (1) by overall dosage unit | 11 | | appearance, including shape,
color, size, markings or lack | 12 | | thereof, taste, consistency, or any other
identifying physical | 13 | | characteristic of the substance, would lead a reasonable
person | 14 | | to believe that the substance is a controlled substance, or (2) | 15 | | is
expressly or impliedly represented to be a controlled | 16 | | substance or is
distributed under circumstances which would | 17 | | lead a reasonable person to
believe that the substance is a | 18 | | controlled substance. For the purpose of
determining whether | 19 | | the representations made or the circumstances of the
| 20 | | distribution would lead a reasonable person to believe the | 21 | | substance to be
a controlled substance under this clause (2) of | 22 | | subsection (y), the court or
other authority may consider the | 23 | | following factors in addition to any other
factor that may be | 24 | | relevant:
| 25 | | (a) statements made by the owner or person in control | 26 | | of the substance
concerning its nature, use or effect;
|
| | | 10000SB1585sam001 | - 72 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (b) statements made to the buyer or recipient that the | 2 | | substance may
be resold for profit;
| 3 | | (c) whether the substance is packaged in a manner | 4 | | normally used for the
illegal distribution of controlled | 5 | | substances;
| 6 | | (d) whether the distribution or attempted distribution | 7 | | included an
exchange of or demand for money or other | 8 | | property as consideration, and
whether the amount of the | 9 | | consideration was substantially greater than the
| 10 | | reasonable retail market value of the substance.
| 11 | | Clause (1) of this subsection (y) shall not apply to a | 12 | | noncontrolled
substance in its finished dosage form that was | 13 | | initially introduced into
commerce prior to the initial | 14 | | introduction into commerce of a controlled
substance in its | 15 | | finished dosage form which it may substantially resemble.
| 16 | | Nothing in this subsection (y) prohibits the dispensing or | 17 | | distributing
of noncontrolled substances by persons authorized | 18 | | to dispense and
distribute controlled substances under this | 19 | | Act, provided that such action
would be deemed to be carried | 20 | | out in good faith under subsection (u) if the
substances | 21 | | involved were controlled substances.
| 22 | | Nothing in this subsection (y) or in this Act prohibits the | 23 | | manufacture,
preparation, propagation, compounding, | 24 | | processing, packaging, advertising
or distribution of a drug or | 25 | | drugs by any person registered pursuant to
Section 510 of the | 26 | | Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
|
| | | 10000SB1585sam001 | - 73 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (y-1) "Mail-order pharmacy" means a pharmacy that is | 2 | | located in a state
of the United States that delivers, | 3 | | dispenses or
distributes, through the United States Postal | 4 | | Service or other common
carrier, to Illinois residents, any | 5 | | substance which requires a prescription.
| 6 | | (z) "Manufacture" means the production, preparation, | 7 | | propagation,
compounding, conversion or processing of a | 8 | | controlled substance other than methamphetamine, either
| 9 | | directly or indirectly, by extraction from substances of | 10 | | natural origin,
or independently by means of chemical | 11 | | synthesis, or by a combination of
extraction and chemical | 12 | | synthesis, and includes any packaging or
repackaging of the | 13 | | substance or labeling of its container, except that
this term | 14 | | does not include:
| 15 | | (1) by an ultimate user, the preparation or compounding | 16 | | of a
controlled substance for his or her own use; or
| 17 | | (2) by a practitioner, or his or her authorized agent | 18 | | under his or her
supervision, the preparation, | 19 | | compounding, packaging, or labeling of a
controlled | 20 | | substance:
| 21 | | (a) as an incident to his or her administering or | 22 | | dispensing of a
controlled substance in the course of | 23 | | his or her professional practice; or
| 24 | | (b) as an incident to lawful research, teaching or | 25 | | chemical
analysis and not for sale.
| 26 | | (z-1) (Blank).
|
| | | 10000SB1585sam001 | - 74 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (z-5) "Medication shopping" means the conduct prohibited | 2 | | under subsection (a) of Section 314.5 of this Act. | 3 | | (z-10) "Mid-level practitioner" means (i) a physician | 4 | | assistant who has been delegated authority to prescribe through | 5 | | a written delegation of authority by a physician licensed to | 6 | | practice medicine in all of its branches, in accordance with | 7 | | Section 7.5 of the Physician Assistant Practice Act of 1987, | 8 | | (ii) an advanced practice nurse who has been delegated | 9 | | authority to prescribe through a written delegation of | 10 | | authority by a physician licensed to practice medicine in all | 11 | | of its branches or by a podiatric physician, in accordance with | 12 | | Section 65-40 of the Nurse Practice Act, (iii) an advanced | 13 | | practice nurse certified as a nurse practitioner, nurse | 14 | | midwife, or clinical nurse specialist who has been granted | 15 | | authority to prescribe by a hospital affiliate in accordance | 16 | | with Section 65-45 of the Nurse Practice Act, (iv) an animal | 17 | | euthanasia agency, or (v) a prescribing psychologist. | 18 | | (aa) "Narcotic drug" means any of the following, whether | 19 | | produced
directly or indirectly by extraction from substances | 20 | | of vegetable origin,
or independently by means of chemical | 21 | | synthesis, or by a combination of
extraction and chemical | 22 | | synthesis:
| 23 | | (1) opium, opiates, derivatives of opium and opiates, | 24 | | including their isomers, esters, ethers, salts, and salts | 25 | | of isomers, esters, and ethers, whenever the existence of | 26 | | such isomers, esters, ethers, and salts is possible within |
| | | 10000SB1585sam001 | - 75 - | LRB100 11277 SMS 24690 a |
|
| 1 | | the specific chemical designation; however the term | 2 | | "narcotic drug" does not include the isoquinoline | 3 | | alkaloids of opium;
| 4 | | (2) (blank);
| 5 | | (3) opium poppy and poppy straw;
| 6 | | (4) coca leaves, except coca leaves and extracts of | 7 | | coca leaves from which substantially all of the cocaine and | 8 | | ecgonine, and their isomers, derivatives and salts, have | 9 | | been removed;
| 10 | | (5) cocaine, its salts, optical and geometric isomers, | 11 | | and salts of isomers; | 12 | | (6) ecgonine, its derivatives, their salts, isomers, | 13 | | and salts of isomers; | 14 | | (7) any compound, mixture, or preparation which | 15 | | contains any quantity of any of the substances referred to | 16 | | in subparagraphs (1) through (6). | 17 | | (bb) "Nurse" means a registered nurse licensed under the
| 18 | | Nurse Practice Act.
| 19 | | (cc) (Blank).
| 20 | | (dd) "Opiate" means any substance having an addiction | 21 | | forming or
addiction sustaining liability similar to morphine | 22 | | or being capable of
conversion into a drug having addiction | 23 | | forming or addiction sustaining
liability.
| 24 | | (ee) "Opium poppy" means the plant of the species Papaver
| 25 | | somniferum L., except its seeds.
| 26 | | (ee-5) "Oral dosage" means a tablet, capsule, elixir, or |
| | | 10000SB1585sam001 | - 76 - | LRB100 11277 SMS 24690 a |
|
| 1 | | solution or other liquid form of medication intended for | 2 | | administration by mouth, but the term does not include a form | 3 | | of medication intended for buccal, sublingual, or transmucosal | 4 | | administration. | 5 | | (ff) "Parole and Pardon Board" means the Parole and Pardon | 6 | | Board of
the State of Illinois or its successor agency.
| 7 | | (gg) "Person" means any individual, corporation, | 8 | | mail-order pharmacy,
government or governmental subdivision or | 9 | | agency, business trust, estate,
trust, partnership or | 10 | | association, or any other entity.
| 11 | | (hh) "Pharmacist" means any person who holds a license or | 12 | | certificate of
registration as a registered pharmacist, a local | 13 | | registered pharmacist
or a registered assistant pharmacist | 14 | | under the Pharmacy Practice Act.
| 15 | | (ii) "Pharmacy" means any store, ship or other place in | 16 | | which
pharmacy is authorized to be practiced under the Pharmacy | 17 | | Practice Act.
| 18 | | (ii-5) "Pharmacy shopping" means the conduct prohibited | 19 | | under subsection (b) of Section 314.5 of this Act. | 20 | | (ii-10) "Physician" (except when the context otherwise | 21 | | requires) means a person licensed to practice medicine in all | 22 | | of its branches. | 23 | | (jj) "Poppy straw" means all parts, except the seeds, of | 24 | | the opium
poppy, after mowing.
| 25 | | (kk) "Practitioner" means a physician licensed to practice | 26 | | medicine in all
its branches, dentist, optometrist, podiatric |
| | | 10000SB1585sam001 | - 77 - | LRB100 11277 SMS 24690 a |
|
| 1 | | physician,
veterinarian, scientific investigator, pharmacist, | 2 | | physician assistant,
advanced practice nurse,
licensed | 3 | | practical
nurse, registered nurse, hospital, laboratory, or | 4 | | pharmacy, or other
person licensed, registered, or otherwise | 5 | | lawfully permitted by the
United States or this State to | 6 | | distribute, dispense, conduct research
with respect to, | 7 | | administer or use in teaching or chemical analysis, a
| 8 | | controlled substance in the course of professional practice or | 9 | | research.
| 10 | | (ll) "Pre-printed prescription" means a written | 11 | | prescription upon which
the designated drug has been indicated | 12 | | prior to the time of issuance; the term does not mean a written | 13 | | prescription that is individually generated by machine or | 14 | | computer in the prescriber's office.
| 15 | | (mm) "Prescriber" means a physician licensed to practice | 16 | | medicine in all
its branches, dentist, optometrist, | 17 | | prescribing psychologist licensed under Section 4.2 of the | 18 | | Clinical Psychologist Licensing Act with prescriptive | 19 | | authority delegated under Section 4.3 of the Clinical | 20 | | Psychologist Licensing Act, podiatric physician, or
| 21 | | veterinarian who issues a prescription, a physician assistant | 22 | | who
issues a
prescription for a controlled substance
in | 23 | | accordance
with Section 303.05, a written delegation, and a | 24 | | written collaborative supervision agreement required under | 25 | | Section 7.5
of the
Physician Assistant Practice Act of 1987, an | 26 | | advanced practice
nurse with prescriptive authority delegated |
| | | 10000SB1585sam001 | - 78 - | LRB100 11277 SMS 24690 a |
|
| 1 | | under Section 65-40 of the Nurse Practice Act and in accordance | 2 | | with Section 303.05, a written delegation,
and a written
| 3 | | collaborative agreement under Section 65-35 of the Nurse | 4 | | Practice Act, or an advanced practice nurse certified as a | 5 | | nurse practitioner, nurse midwife, or clinical nurse | 6 | | specialist who has been granted authority to prescribe by a | 7 | | hospital affiliate in accordance with Section 65-45 of the | 8 | | Nurse Practice Act and in accordance with Section 303.05.
| 9 | | (nn) "Prescription" means a written, facsimile, or oral | 10 | | order, or an electronic order that complies with applicable | 11 | | federal requirements,
of
a physician licensed to practice | 12 | | medicine in all its branches,
dentist, podiatric physician or | 13 | | veterinarian for any controlled
substance, of an optometrist in | 14 | | accordance with Section 15.1 of the Illinois Optometric | 15 | | Practice Act of 1987, of a prescribing psychologist licensed | 16 | | under Section 4.2 of the Clinical Psychologist Licensing Act | 17 | | with prescriptive authority delegated under Section 4.3 of the | 18 | | Clinical Psychologist Licensing Act, of a physician assistant | 19 | | for a
controlled substance
in accordance with Section 303.05, a | 20 | | written delegation, and a written collaborative supervision | 21 | | agreement required under
Section 7.5 of the
Physician Assistant | 22 | | Practice Act of 1987, of an advanced practice
nurse with | 23 | | prescriptive authority delegated under Section 65-40 of the | 24 | | Nurse Practice Act who issues a prescription for a
controlled | 25 | | substance in accordance
with
Section 303.05, a written | 26 | | delegation, and a written collaborative agreement under |
| | | 10000SB1585sam001 | - 79 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Section 65-35 of the Nurse Practice Act, or of an advanced | 2 | | practice nurse certified as a nurse practitioner, nurse | 3 | | midwife, or clinical nurse specialist who has been granted | 4 | | authority to prescribe by a hospital affiliate in accordance | 5 | | with Section 65-45 of the Nurse Practice Act and in accordance | 6 | | with Section 303.05 when required by law.
| 7 | | (nn-5) "Prescription Information Library" (PIL) means an | 8 | | electronic library that contains reported controlled substance | 9 | | data. | 10 | | (nn-10) "Prescription Monitoring Program" (PMP) means the | 11 | | entity that collects, tracks, and stores reported data on | 12 | | controlled substances and select drugs pursuant to Section 316. | 13 | | (oo) "Production" or "produce" means manufacture, | 14 | | planting,
cultivating, growing, or harvesting of a controlled | 15 | | substance other than methamphetamine.
| 16 | | (pp) "Registrant" means every person who is required to | 17 | | register
under Section 302 of this Act.
| 18 | | (qq) "Registry number" means the number assigned to each | 19 | | person
authorized to handle controlled substances under the | 20 | | laws of the United
States and of this State.
| 21 | | (qq-5) "Secretary" means, as the context requires, either | 22 | | the Secretary of the Department or the Secretary of the | 23 | | Department of Financial and Professional Regulation, and the | 24 | | Secretary's designated agents. | 25 | | (rr) "State" includes the State of Illinois and any state, | 26 | | district,
commonwealth, territory, insular possession thereof, |
| | | 10000SB1585sam001 | - 80 - | LRB100 11277 SMS 24690 a |
|
| 1 | | and any area
subject to the legal authority of the United | 2 | | States of America.
| 3 | | (rr-5) "Stimulant" means any drug that (i) causes an | 4 | | overall excitation of central nervous system functions, (ii) | 5 | | causes impaired consciousness and awareness, and (iii) can be | 6 | | habit-forming or lead to a substance abuse problem, including | 7 | | but not limited to amphetamines and their analogs, | 8 | | methylphenidate and its analogs, cocaine, and phencyclidine | 9 | | and its analogs. | 10 | | (ss) "Ultimate user" means a person who lawfully possesses | 11 | | a
controlled substance for his or her own use or for the use of | 12 | | a member of his or her
household or for administering to an | 13 | | animal owned by him or her or by a member
of his or her | 14 | | household.
| 15 | | (Source: P.A. 98-214, eff. 8-9-13; 98-668, eff. 6-25-14; | 16 | | 98-756, eff. 7-16-14; 98-1111, eff. 8-26-14; 99-78, eff. | 17 | | 7-20-15; 99-173, eff. 7-29-15; 99-371, eff. 1-1-16; 99-480, | 18 | | eff. 9-9-15; 99-642, eff. 7-28-16.)
| 19 | | (720 ILCS 570/303.05)
| 20 | | Sec. 303.05. Mid-level practitioner registration.
| 21 | | (a) The Department of Financial and Professional | 22 | | Regulation shall register licensed
physician assistants, | 23 | | licensed advanced practice nurses, and prescribing | 24 | | psychologists licensed under Section 4.2 of the Clinical | 25 | | Psychologist Licensing Act to prescribe and
dispense |
| | | 10000SB1585sam001 | - 81 - | LRB100 11277 SMS 24690 a |
|
| 1 | | controlled substances under Section 303 and euthanasia
| 2 | | agencies to purchase, store, or administer animal euthanasia | 3 | | drugs under the
following circumstances:
| 4 | | (1) with respect to physician assistants,
| 5 | | (A) the physician assistant has been
delegated
| 6 | | written authority to prescribe any Schedule III | 7 | | through V controlled substances by a physician | 8 | | licensed to practice medicine in all its
branches in | 9 | | accordance with Section 7.5 of the Physician Assistant | 10 | | Practice Act
of 1987;
and
the physician assistant has
| 11 | | completed the
appropriate application forms and has | 12 | | paid the required fees as set by rule;
or
| 13 | | (B) the physician assistant has been delegated
| 14 | | authority by a collaborating supervising physician | 15 | | licensed to practice medicine in all its branches to | 16 | | prescribe or dispense Schedule II controlled | 17 | | substances through a written delegation of authority | 18 | | and under the following conditions: | 19 | | (i) Specific Schedule II controlled substances | 20 | | by oral dosage or topical or transdermal | 21 | | application may be delegated, provided that the | 22 | | delegated Schedule II controlled substances are | 23 | | routinely prescribed by the collaborating | 24 | | supervising physician. This delegation must | 25 | | identify the specific Schedule II controlled | 26 | | substances by either brand name or generic name. |
| | | 10000SB1585sam001 | - 82 - | LRB100 11277 SMS 24690 a |
|
| 1 | | Schedule II controlled substances to be delivered | 2 | | by injection or other route of administration may | 3 | | not be delegated; | 4 | | (ii) any delegation must be of controlled | 5 | | substances prescribed by the collaborating | 6 | | supervising physician; | 7 | | (iii) all prescriptions must be limited to no | 8 | | more than a 30-day supply, with any continuation | 9 | | authorized only after prior approval of the | 10 | | collaborating supervising physician; | 11 | | (iv) the physician assistant must discuss the | 12 | | condition of any patients for whom a controlled | 13 | | substance is prescribed monthly with the | 14 | | delegating physician; | 15 | | (v) the physician assistant must have | 16 | | completed the appropriate application forms and | 17 | | paid the required fees as set by rule; | 18 | | (vi) the physician assistant must provide | 19 | | evidence of satisfactory completion of 45 contact | 20 | | hours in pharmacology from any physician assistant | 21 | | program accredited by the Accreditation Review | 22 | | Commission on Education for the Physician | 23 | | Assistant (ARC-PA), or its predecessor agency, for | 24 | | any new license issued with Schedule II authority | 25 | | after the effective date of this amendatory Act of | 26 | | the 97th General Assembly; and |
| | | 10000SB1585sam001 | - 83 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (vii) the physician assistant must annually | 2 | | complete at least 5 hours of continuing education | 3 | | in pharmacology; | 4 | | (2) with respect to advanced practice nurses, | 5 | | (A) the advanced practice nurse has been delegated
| 6 | | authority to prescribe any Schedule III through V | 7 | | controlled substances by a collaborating physician | 8 | | licensed to practice medicine in all its branches or a | 9 | | collaborating podiatric physician in accordance with | 10 | | Section 65-40 of the Nurse Practice
Act. The advanced | 11 | | practice nurse has completed the
appropriate | 12 | | application forms and has paid the required
fees as set | 13 | | by rule; or | 14 | | (B) the advanced practice nurse has been delegated
| 15 | | authority by a collaborating physician licensed to | 16 | | practice medicine in all its branches or collaborating | 17 | | podiatric physician to prescribe or dispense Schedule | 18 | | II controlled substances through a written delegation | 19 | | of authority and under the following conditions: | 20 | | (i) specific Schedule II controlled substances | 21 | | by oral dosage or topical or transdermal | 22 | | application may be delegated, provided that the | 23 | | delegated Schedule II controlled substances are | 24 | | routinely prescribed by the collaborating | 25 | | physician or podiatric physician. This delegation | 26 | | must identify the specific Schedule II controlled |
| | | 10000SB1585sam001 | - 84 - | LRB100 11277 SMS 24690 a |
|
| 1 | | substances by either brand name or generic name. | 2 | | Schedule II controlled substances to be delivered | 3 | | by injection or other route of administration may | 4 | | not be delegated; | 5 | | (ii) any delegation must be of controlled | 6 | | substances prescribed by the collaborating | 7 | | physician or podiatric physician; | 8 | | (iii) all prescriptions must be limited to no | 9 | | more than a 30-day supply, with any continuation | 10 | | authorized only after prior approval of the | 11 | | collaborating physician or podiatric physician; | 12 | | (iv) the advanced practice nurse must discuss | 13 | | the condition of any patients for whom a controlled | 14 | | substance is prescribed monthly with the | 15 | | delegating physician or podiatric physician or in | 16 | | the course of review as required by Section 65-40 | 17 | | of the Nurse Practice Act; | 18 | | (v) the advanced practice nurse must have | 19 | | completed the appropriate application forms and | 20 | | paid the required fees as set by rule; | 21 | | (vi) the advanced practice nurse must provide | 22 | | evidence of satisfactory completion of at least 45 | 23 | | graduate contact hours in pharmacology for any new | 24 | | license issued with Schedule II authority after | 25 | | the effective date of this amendatory Act of the | 26 | | 97th General Assembly; and |
| | | 10000SB1585sam001 | - 85 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (vii) the advanced practice nurse must | 2 | | annually complete 5 hours of continuing education | 3 | | in pharmacology; | 4 | | (2.5) with respect to advanced practice nurses | 5 | | certified as nurse practitioners, nurse midwives, or | 6 | | clinical nurse specialists practicing in a hospital | 7 | | affiliate, | 8 | | (A) the advanced practice nurse certified as a | 9 | | nurse practitioner, nurse midwife, or clinical nurse | 10 | | specialist has been granted authority to prescribe any | 11 | | Schedule II through V controlled substances by the | 12 | | hospital affiliate upon the recommendation of the | 13 | | appropriate physician committee of the hospital | 14 | | affiliate in accordance with Section 65-45 of the Nurse | 15 | | Practice Act, has completed the appropriate | 16 | | application forms, and has paid the required fees as | 17 | | set by rule; and | 18 | | (B) an advanced practice nurse certified as a nurse | 19 | | practitioner, nurse midwife, or clinical nurse | 20 | | specialist has been granted authority to prescribe any | 21 | | Schedule II controlled substances by the hospital | 22 | | affiliate upon the recommendation of the appropriate | 23 | | physician committee of the hospital affiliate, then | 24 | | the following conditions must be met: | 25 | | (i) specific Schedule II controlled substances | 26 | | by oral dosage or topical or transdermal |
| | | 10000SB1585sam001 | - 86 - | LRB100 11277 SMS 24690 a |
|
| 1 | | application may be designated, provided that the | 2 | | designated Schedule II controlled substances are | 3 | | routinely prescribed by advanced practice nurses | 4 | | in their area of certification; this grant of | 5 | | authority must identify the specific Schedule II | 6 | | controlled substances by either brand name or | 7 | | generic name; authority to prescribe or dispense | 8 | | Schedule II controlled substances to be delivered | 9 | | by injection or other route of administration may | 10 | | not be granted; | 11 | | (ii) any grant of authority must be controlled | 12 | | substances limited to the practice of the advanced | 13 | | practice nurse; | 14 | | (iii) any prescription must be limited to no | 15 | | more than a 30-day supply; | 16 | | (iv) the advanced practice nurse must discuss | 17 | | the condition of any patients for whom a controlled | 18 | | substance is prescribed monthly with the | 19 | | appropriate physician committee of the hospital | 20 | | affiliate or its physician designee; and | 21 | | (v) the advanced practice nurse must meet the | 22 | | education requirements of this Section; | 23 | | (3) with respect to animal euthanasia agencies, the | 24 | | euthanasia agency has
obtained a license from the | 25 | | Department of
Financial and Professional Regulation and | 26 | | obtained a registration number from the
Department; or
|
| | | 10000SB1585sam001 | - 87 - | LRB100 11277 SMS 24690 a |
|
| 1 | | (4) with respect to prescribing psychologists, the | 2 | | prescribing psychologist has been delegated
authority to | 3 | | prescribe any nonnarcotic Schedule III through V | 4 | | controlled substances by a collaborating physician | 5 | | licensed to practice medicine in all its branches in | 6 | | accordance with Section 4.3 of the Clinical Psychologist | 7 | | Licensing Act, and the prescribing psychologist has | 8 | | completed the
appropriate application forms and has paid | 9 | | the required
fees as set by rule. | 10 | | (b) The mid-level practitioner shall only be licensed to | 11 | | prescribe those
schedules of controlled substances for which a | 12 | | licensed physician or licensed podiatric physician has | 13 | | delegated
prescriptive authority, except that an animal | 14 | | euthanasia agency does not have any
prescriptive authority.
A | 15 | | physician assistant and an advanced practice nurse are | 16 | | prohibited from prescribing medications and controlled | 17 | | substances not set forth in the required written delegation of | 18 | | authority.
| 19 | | (c) Upon completion of all registration requirements, | 20 | | physician
assistants, advanced practice nurses, and animal | 21 | | euthanasia agencies may be issued a
mid-level practitioner
| 22 | | controlled substances license for Illinois.
| 23 | | (d) A collaborating physician or podiatric physician may, | 24 | | but is not required to, delegate prescriptive authority to an | 25 | | advanced practice nurse as part of a written collaborative | 26 | | agreement, and the delegation of prescriptive authority shall |
| | | 10000SB1585sam001 | - 88 - | LRB100 11277 SMS 24690 a |
|
| 1 | | conform to the requirements of Section 65-40 of the Nurse | 2 | | Practice Act. | 3 | | (e) A collaborating supervising physician may, but is not | 4 | | required to, delegate prescriptive authority to a physician | 5 | | assistant as part of a written collaborative supervision | 6 | | agreement, and the delegation of prescriptive authority shall | 7 | | conform to the requirements of Section 7.5 of the Physician | 8 | | Assistant Practice Act of 1987. | 9 | | (f) Nothing in this Section shall be construed to prohibit | 10 | | generic substitution. | 11 | | (Source: P.A. 98-214, eff. 8-9-13; 98-668, eff. 6-25-14; | 12 | | 99-173, eff. 7-29-15.)
| 13 | | Section 99. Effective date. This Act takes effect upon | 14 | | becoming law.".
|
|